JPH0428717B2 - - Google Patents
Info
- Publication number
- JPH0428717B2 JPH0428717B2 JP57502412A JP50241282A JPH0428717B2 JP H0428717 B2 JPH0428717 B2 JP H0428717B2 JP 57502412 A JP57502412 A JP 57502412A JP 50241282 A JP50241282 A JP 50241282A JP H0428717 B2 JPH0428717 B2 JP H0428717B2
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- hydroxy
- glycoside
- glycosidic
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 abstract description 39
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 18
- 239000011575 calcium Substances 0.000 abstract description 18
- 229910052791 calcium Inorganic materials 0.000 abstract description 18
- 239000001257 hydrogen Substances 0.000 abstract description 12
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 12
- 241001465754 Metazoa Species 0.000 abstract description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 150000002431 hydrogen Chemical class 0.000 abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 27
- 150000002338 glycosides Chemical class 0.000 description 25
- 229940088594 vitamin Drugs 0.000 description 23
- 239000011782 vitamin Substances 0.000 description 23
- 239000011647 vitamin D3 Substances 0.000 description 22
- 229930003231 vitamin Natural products 0.000 description 21
- 235000013343 vitamin Nutrition 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 229930182470 glycoside Natural products 0.000 description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 17
- 150000003710 vitamin D derivatives Chemical class 0.000 description 16
- 150000003722 vitamin derivatives Chemical class 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000011710 vitamin D Substances 0.000 description 15
- 235000019166 vitamin D Nutrition 0.000 description 15
- 229930003316 Vitamin D Natural products 0.000 description 14
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 14
- 229940046008 vitamin d Drugs 0.000 description 14
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 11
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 11
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 11
- -1 artose Chemical compound 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 5
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 5
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 5
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 229910001958 silver carbonate Inorganic materials 0.000 description 5
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 208000013038 Hypocalcemia Diseases 0.000 description 4
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
- DLRVVLDZNNYCBX-CQHUIXDMSA-N alpha-D-Galp-(1->6)-alpha-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)O1 DLRVVLDZNNYCBX-CQHUIXDMSA-N 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 4
- 230000000705 hypocalcaemia Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- 125000001797 benzyl group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 102000006995 beta-Glucosidase Human genes 0.000 description 3
- 108010047754 beta-Glucosidase Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000011653 vitamin D2 Substances 0.000 description 3
- 150000008505 β-D-glucopyranosides Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- WFZKUWGUJVKMHC-DRLBFNKMSA-N (1r,3s,5e)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r,5r)-5,6-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)=C\C=C1/C[C@@H](O)C[C@H](O)C1=C WFZKUWGUJVKMHC-DRLBFNKMSA-N 0.000 description 2
- LUMQIGNPUDCMLN-SEZLTJOTSA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r,6s)-6,7-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC[C@](C)(O)CO)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C LUMQIGNPUDCMLN-SEZLTJOTSA-N 0.000 description 2
- KRGCLKZOZQUAFK-ABEKVIRTSA-N (24R)-1alpha,24,25-Trihydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@@](C)(O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C KRGCLKZOZQUAFK-ABEKVIRTSA-N 0.000 description 2
- QOWCBCXATJITSI-ZLNGONTQSA-N (6r)-6-[(1r,3as,4e,7ar)-4-[(2z)-2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-1-yl]-2-methylheptane-1,2-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(O)CO)C)=C\C=C1\C[C@@H](O)CCC1=C QOWCBCXATJITSI-ZLNGONTQSA-N 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 2
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 2
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 2
- RQBSUMJKSOSGJJ-AGQMPKSLSA-N D-lyxosylamine Chemical compound NC1OC[C@@H](O)[C@H](O)[C@@H]1O RQBSUMJKSOSGJJ-AGQMPKSLSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-OBAJZVCXSA-N Gentianose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@H](O)[C@@H](CO)O2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-OBAJZVCXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 2
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011612 calcitriol Substances 0.000 description 2
- 230000003913 calcium metabolism Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 230000020176 deacylation Effects 0.000 description 2
- 238000005947 deacylation reaction Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- HKXBNHCUPKIYDM-CGMHZMFXSA-N doxercalciferol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C HKXBNHCUPKIYDM-CGMHZMFXSA-N 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- MUPFEKGTMRGPLJ-WSCXOGSTSA-N gentianose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-WSCXOGSTSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000001184 hypocalcaemic effect Effects 0.000 description 2
- 150000002454 idoses Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- KJKIIUAXZGLUND-QVKZFZTCSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-1-[(e,2r,5r)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C KJKIIUAXZGLUND-QVKZFZTCSA-N 0.000 description 1
- FCKJYANJHNLEEP-XRWYNYHCSA-N (24R)-24,25-dihydroxycalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-XRWYNYHCSA-N 0.000 description 1
- BPEQZNMKGFTMQE-LXHCYJFYSA-N (e,3r,6r)-6-[(1r,3as,4e,7ar)-4-[(2z)-2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-1-yl]-2,3-dimethylhept-4-ene-2,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@@](C)(O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C BPEQZNMKGFTMQE-LXHCYJFYSA-N 0.000 description 1
- AKIVKIDZMLQJCH-UHFFFAOYSA-N 12738-64-6 Chemical group C=1C=CC=CC=1C(=O)OCC(C(C1OC(=O)C=2C=CC=CC=2)OC(=O)C=2C=CC=CC=2)OC1(OC1C(C(OC(=O)C=2C=CC=CC=2)C(OC(=O)C=2C=CC=CC=2)C(COC(=O)C=2C=CC=CC=2)O1)OC(=O)C=1C=CC=CC=1)COC(=O)C1=CC=CC=C1 AKIVKIDZMLQJCH-UHFFFAOYSA-N 0.000 description 1
- ZGLHBRQAEXKACO-XJRQOBMKSA-N 1alpha,25-dihydroxyvitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](\C=C\[C@H](C)C(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C ZGLHBRQAEXKACO-XJRQOBMKSA-N 0.000 description 1
- ZTTRCZJSZGZSTB-XGWBRSPTSA-N 3-O-beta-D-galactopyranosyl-D-arabinose Chemical compound OC[C@@H](O)[C@H]([C@H](O)C=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O ZTTRCZJSZGZSTB-XGWBRSPTSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010055851 Acetylglucosaminidase Proteins 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241001671627 Cestrum diurnum Species 0.000 description 1
- 241000287226 Charonia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- YPZMPEPLWKRVLD-PJEQPVAWSA-N D-Glycero-D-gulo-Heptose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O YPZMPEPLWKRVLD-PJEQPVAWSA-N 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- HSNZZMHEPUFJNZ-QMTIVRBISA-N D-keto-manno-heptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-QMTIVRBISA-N 0.000 description 1
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- OVRNDRQMDRJTHS-ZTVVOAFPSA-N N-acetyl-D-mannosamine Chemical compound CC(=O)N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-ZTVVOAFPSA-N 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical class CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000511905 Solanum glaucophyllum Species 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- 235000015414 Urena lobata Nutrition 0.000 description 1
- 240000006064 Urena lobata Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WISUUJSJSA-N aldehydo-L-xylose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WISUUJSJSA-N 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
- 102000002014 alpha-N-Acetylgalactosaminidase Human genes 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 108010008753 beta-N-Acetyl-Galactosaminidase Proteins 0.000 description 1
- 238000012658 bimolecular nucleophilic substitution Methods 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003843 furanosyl group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 150000008131 glucosides Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002336 glycosamine derivatives Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 125000006277 halobenzyl group Chemical class 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000000121 hypercalcemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002597 lactoses Chemical class 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 125000006502 nitrobenzyl group Chemical class 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000006409 renal osteodystrophy Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- GKUQBELMWYQKKJ-BNWJMWRWSA-N sedoheptulosan Chemical compound O1[C@@H]2CO[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H]2O GKUQBELMWYQKKJ-BNWJMWRWSA-N 0.000 description 1
- GKUQBELMWYQKKJ-UHFFFAOYSA-N sedoheptulosan Natural products O1C2COC1(CO)C(O)C(O)C2O GKUQBELMWYQKKJ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003703 vitamin D2 derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Description
è«æ±ã®ç¯å²
ïŒ åç©ã«ãããã«ã«ã·ãŠã åã³ãªã³ä»£è¬ãç¶æ
ããäžã§çç©åŠçã«æŽ»æ§ãªäžèšäžè¬åŒã§è¡šãã
ããåæååç©ïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãã¡ãã«æã
ã¯ãšãã«ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã矀
ããéžã°ããR1ã¯ãã°ã«ã³ãŒã¹ããã³ããŒã¹ã
ã¬ã©ã¯ããŒã¹ãã°ããŒã¹ãã¢ããŒã¹ãã¢ã«ãããŒ
ã¹ãã€ããŒã¹ãã¿ããŒã¹ããã©ã¯ããŒã¹ãã¢ã©ã
ããŒã¹ããã·ããŒã¹ãã¹ã¯ããŒã¹ãã»ãããªãŒ
ã¹ããã«ããŒã¹ãã©ã¯ããŒã¹ããã¬ãããŒã¹ãã²
ã³ããªããªãŒã¹ãã¡ãªããªãŒã¹ãã©ãã€ããŒã¹ã
ã²ã³ãã¢ããŒã¹ãâã¢ã»ãã«ââã¬ã©ã¯ããµ
ãã³ãâã¢ã»ãã«ââã°ã«ã³ãµãã³ãâã¢
ã»ãã«ââãã³ããµãã³ãâã¢ã»ãã«ãã€ã©
ãã³é žãâã°ã«ã³ãµãã³ããªããœã·ã«ã¢ãã³ã
ãã³ïŒ€âã¬ã©ã¯ããµãã³ãããªã矀ããéžã°ãã
ã°ãªã³ã·ãã§ãããååç©åœãã®ã°ãªã³ã·ãåäœ
ã®ç·æ°ãïŒä»¥äžã§ããïŒã ïŒ ïŒ£âïŒäœã®çµåãβã§ãããè«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒ ïŒ£âïŒäœã®ïŒžãOR1ã§ããå ŽåãâïŒäœã«
ãããçµåãαã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ã ïŒ ïŒ£â22åã³ïŒ£â23éã®çµåãåäžã§ããã
R2ïŒïŒšã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ R1ãã°ã«ã³ãŒã¹ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒïŒ ååç©ããã¿ãã³D3â3βââã°ã«ã³ã·
ãã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ã25âïŒã°ã«ã³ã·ãïŒâãã¿ãã³D3
ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ãïŒïŒ25âãžããããã· ãã¿ãã³
D3â3βââã°ã«ã³ã·ãã§ãããè«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ã25âããããã· ãã¿ãã³D3â
3βââã°ã«ã³ã·ãã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ã ïŒïŒ ååç©ãïŒâããããã·â25âã°ã«ã³ã·ã
âãã¿ãã³D3ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ãæçŽ°æž æè¡åé æ¬çºæã¯ãã¿ãã³ïŒ€ã®æ°Žæº¶æ§åæã°ãªã³ã·ãé¡
åã³ã«ã«ã·ãŠã 代è¬ã®å¶åŸ¡ã«ããããã®çšéã«é¢
ããã èæ¯æè¡ ãã¿ãã³D3æ¬ ä¹ãå³ã¡ãã¿ãã³D3ã®ä»£è¬ã«ã
ããé害ã¯ãããç ãè è骚ãžã¹ãããã€ãŒãå
ã³é¢é£ãã骚ç 䞊ã³ã«ãäžè¬çã«ãäœâåã³é«ã«
ã«ã·ãŠã è¡çç¶æ ãªã©ã®ç æ°ãåŒèµ·ãããåŸã€
ãŠããã¿ãã³D3åã³ãã®ä»£è¬ç©è³ªã¯ãè¡æ¶²ã®ã«
ã«ã·ãŠã æ¿åºŠãå¶åŸ¡ããããšã«ãã骚æ§é ã®æ£åžž
ãªçºè²ãç¶æããäžã«æ¥µããŠéèŠã§ããã ãã¿ãã³D3ã¯èèã«ãããŠéãã«25â0HâD3
ã«è»¢æããããäœã«ã«ã·ãŠã è¡çã«å¿çããŠãã
ã¿ãã³ã®äž»ãã埪ç°ä»£è¬ç©ã§ãã25â0HâD3
ã¯ãè èã«ãããŠ1αïŒ25âïŒOHïŒ2D3ã«æŽã«ä»£è¬
ãããã1αïŒ25âïŒOHïŒ2D3ã¯ãD3æãã¯25â
OHâD3ã®ãããããè¿ éã«äœçšãããæŽã«ãã
ã®ãã¿ãã³ã®ãžããããã·åœ¢æ ç©ã¯éçµå£çã«ã
äžã€æ¯æ¥æäžããããªãã°ãçäœå ã§D3ããã
ïŒã10å匷åã§ããããã®ãã¿ãã³ã®ã¢ãããã
ãã·åœ¢æ ãããïŒãïŒå匷åã§ããïŒJ.L.Napoli
åã³H.F.DelucaïŒâBlood Calcium Regulatorsâ
åã³ããã«åŒçšãããŠããæç®ãããŒã¬ãŒ
ïŒBurgerïŒã®ãå»ååŠãïŒMedicinal ChemistryïŒ
第ïŒçã第éšãManfred Wolfç·šãWileyâ
InterscienceïŒ1979幎ã725ã739é ïŒã ãã¿ãã³D2ããã¿ãã³D3æãã¯ïŒïŒïŒïŒ25ïŒ
ïŒïŒ24ïŒ25ïŒ24ïŒ25ïŒ25ïŒ26ïŒæãã¯ïŒïŒ25ïŒ26
ã®äœçœ®ã«ãããŠããããã·ã«åãããŠããããã
ã®ä»£è¬ç©ã¯æ°Žäžæº¶æ§ååç©ã§ãããè¬åãæ°Žæ§ç°
å¢æãã¯èè žç®¡è ã«ãããŠæ¯èŒçäžæº¶æ§ã§ããå Ž
åã«ã¯ãæäžåŸã®æº¶è§£æ§ãè¬ååžåã«ãããåŸé
段éãšãªãåŸããä»æ¹ã氎溶æ§è¬åã«ãããŠã¯ã
溶解ãè¿ éã«èµ·ãããåŸã€ãŠãè¡æ¶²ãéããŠã®æŽ»
æ§éšäœãžã®èŒžéã容æã«ãããåŸã€ãŠã芪氎æ§å
ã³ïŒåã¯æ°Žæº¶æ§ã§ããããªãäžã€æ°Žäžæº¶æ§è¬åã®
æ£åžžãªçç©åŠçç¹æ§ãä¿ã€ãã¿ãã³ïŒ€ïŒD3åã¯
D2ïŒã®åœ¢æ ç©ãæäŸããããšãæãŸããŠããã åã¢ã¡ãªã«ã®æ€ç©Solanum malacoxylonïŒä»¥
äžãS.m.ããšç§°ããïŒã®èããã®æœåºç©ããïŒïŒ
25ïŒHOïŒ2D3ãšç°ãããããŠã°ãªã³ã·ããŒãŒé µçŽ
ã§åŠçãããšïŒïŒ25ïŒOHïŒ2D3åã³æ°Žæº¶æ§æªåå®
æçãçæãã氎溶æ§æåãå«æããŠããããšã
確èªãããŠãããäŸãã°ãM.R.Hausslerçã
Life SciencesïŒ18å·»1049â1056ïŒ1976幎ïŒïŒR.H.
WassermançãScienâce 194å·»ã853â855
ïŒ1976幎ïŒïŒJ.L.NapoliçãThe Journal of
Biologiâcal ChemistryïŒ252å·»ã2580â2583
ïŒ1977幎ïŒãã ã°ãªã³ã·ããŒãŒã§åŠçãããšïŒïŒ25ãžãããã
ã·ãã¿ãã³D3ãçæãã極ããŠé¡äŒŒãã氎溶æ§
æåãCestrum diurnumã以äžãc.d.ããšç§°ã
ãïŒM.R.HughesçãNatureïŒ268å·»ã347â349
ïŒ1977幎ïŒããšããæ€ç©ã«èŠåºãããŠãããããã
ã®S.m.æãã¯C.d.ããã®æ°Žæº¶æ§æœåºç©ã¯1αïŒ25â
ãžããããã·ãã¿ãã³D3ã®ããã«é¡äŒŒããçç©
åŠç掻æ§ãæããã ãããã®æ€ç©ããã®æ°Žæº¶æ§æåã®ã°ãªã³ã·ããŒ
ãŒåŠçã®éã«æŸåºããã氎溶æ§æçã®æ§é ã«é¢ã
ãä»æ¥ãŸã§ã«ååšããå¯äžã®èšŒæ ã¯æå³ã§ããã
åèšåè¡ç©ã®èè çã¯ãé µçŽ ç蚌æ ã氎溶æ§åã³
ååŠæ€åºè©Šè¬ã®äœ¿çšã«åºã¥ããŠããã®æ§é ã¯ãã
ããã°ãªã³ã·ãã§ãããšçµè«ä»ããŠãããN.
Peterlikåã³R.H.WassermanïŒFEBS LettïŒ56
å·»ïŒ16â19ïŒ1973幎ïŒããããããªããããã³ããª
ãŒãºïŒHumphreysïŒãNatureïŒLondonïŒNew
Biology 246å·»ïŒ155ïŒ1973ïŒãã¯ãã¢ãªãã·ãŠ
ïŒMolishïŒçæ°Žåç©è©Šéšããã®æåã«å¯ŸããŠé°æ§
ã§ããããšãå®èšŒãããã®çµè«ã«ã€ããŠçåãæ
ããããã é µçŽ åå¿æŸåºåã®æ°Žæº¶æ§ãã¿ãã³D3å«ææå
ã®ååéã¯ã1000ããçžåœå€§ããããšç¥ãããŠã
ãã®ã§ãD.J.HumphreysïŒNatureïŒLondonïŒ
New Biology 246å·»ïŒ155ïŒ1973幎ïŒããé µçŽ å æ°Ž
å解ã«ããæŸåºããã氎溶æ§è€åæçã®ååéã¯
584ãããçžåœã«å€§ãããšèšç®ããããšãã§ãã
ãžããããã·ãã¿ãã³D3ã®ååéã¯416ã§ããã
ãã®æ§ã«é µçŽ å æ°Žå解ã«ããæŸåºããã氎溶æ§æ
çãäºå®ã°ãªã³ã·ãã§ãããªãã°ãããã¯ãïŒå
ãè¶ããã°ãªã³ã·ãïŒã°ãªã³ãã©ãã·ã«æãã¯ã°
ãªã³ãã©ãã·ã«ïŒåäœãæãããã®ã§ãããã æŽã«ãé µçŽ åå¿æŸåºã®çµæã¯ãåçš®ã®æ§é ãšå
åã«äžèŽãããã®ã§ãããäŸãã°ãM.R.
HausslerçãLife Sciences 18ïŒ1049â1056
ïŒ1976幎ïŒãã¯ãCharonia Iampusã«ç±æ¥ããæ··
åã°ãªã³ã·ããŒãŒãçšããŠãã®æ°Žæº¶æ§æåãå æ°Ž
å解ããããšãé瀺ããŠããããã®é µçŽ ã¯ãçŸå®
ã«ã¯äžèšã®åŠãé µçŽ ã®æ··åç©ã§ããïŒMiles
LaboâratoriesïŒ1977幎ã«ã¿ãã°ïŒïŒÎ²âã°ã«ã³
ã·ããŒãŒïŒ11åäœïŒãαâãã³ãã·ããŒãŒïŒ33å
äœïŒãβâãã³ãã·ããŒãŒïŒ5.2åäœïŒãαâã°ã«
ã³ã·ããŒãŒãβâã°ã«ã³ã·ããŒãŒïŒ4.8åäœïŒãβ
âã¬ã©ã¯ãã·ããŒãŒïŒ44åäœïŒãαâã¬ã©ã¯ãã·
ããŒãŒïŒ26åäœïŒãαâãã³ã·ããŒãŒïŒ24åäœïŒã
βâãã·ãã·ããŒãŒïŒ8.2åäœïŒãβââã¢ã»ã
ã«ã°ã«ã³ãµããããŒãŒïŒ210åäœïŒãαââã¢ã»
ãã«ã¬ã©ã¯ããµããããŒãŒïŒ41åäœïŒãåã³Î²â
âã¢ã»ãã«ã¬ã©ã¯ããµããããŒãŒïŒ25åäœïŒã
ããŒã¿ãŒãªã«ïŒM.PeterlikïŒçãBiochemical
and Biaphysical Research Communicatâions
70å·»ïŒ797â804ïŒ1976幎ïŒãã¯ãã·ã°ãååŠ
ïŒSigma ChemicalïŒç€Ÿè£œã®Î²âã°ã«ã³ã·ããŒãŒ
ïŒã¢ãŒã¢ã³ãïŒãçšããS.m.æœåºç©ã®ç 究ã«ãã
ãŠãæŽã«Î²ââã¬ã©ã¯ãã·ããŒãŒãåã³Î±â
âãã³ãã·ããŒãŒæŽ»æ§ãã·ã°ãååŠç€Ÿã1981幎ïŒ
æã«ã¿ãã°ïŒæŽã«J.SchwartzçArchivâes of
Biochemistry and Biophysiâcsã137å·»ïŒ122â
127ïŒ1970幎ïŒåç §ãããå«æããé µçŽ ãå©çšã
ãã èŠããã«ããããã®èè ã«ãã芳å¯ãããçµæ
ã¯ãåºç¯å²ã®æ§é ã«åèŽãããã®ã§ããããã®ã
ãããè¯ãç¹æ§åä»ããããŠããªãããããšãã°
ãªã³ã·ãé¡ãšèšŒæãããã«ããããã¿ãã³ïŒ€åäœ
åœãå°ãªããšãïŒåãè¶ããã°ãªã³ã·ãåäœãå«
æãããã®ã§ããã åŸã€ãŠãäœã«ã«ã·ãŠã è¡çã«å¯ŸããŠæŽ»æ§ã§ã
ããã«ã«ã·ãŠã åã³ãªã³ã®ãã¡ãªã¹ã¿ã·ã¹
ïŒhomeostaâsisïŒãç¶æãããæ確ã«å®çŸ©ãã
è¯ãç¹æ§ä»ãããããã¿ãã³ïŒ€ã®æ°Žæº¶æ§åœ¢æ ç©ã«
ã€ããŠã®éèŠãåç¶ããŠããã çºæã®é瀺 åŸã€ãŠãæ¬çºæã®ç®çã¯ããã¿ãã³D3ããã¿
ãã³D2åã³ãããã®ããããã·ã«å代è¬ç©ã®è¯
ãç¹æ§ä»ããããæ確ã«å®çŸ©ãããåæ氎溶æ§åœ¢
æ ç©ãæäŸããããšã«ããã æ¬çºæã®ä»ã®ç®çã¯ãäœã«ã«ã·ãŠã è¡çã«å¯Ÿã
ãŠæŽ»æ§ã§ãããåç©äœå ã«ãããŠã«ã«ã·ãŠã åã³
ãªã³ãã¡ãªã¹ã¿ã·ã¹ãç¶æãã掻æ§ãæããåèš
ãã¿ãã³ïŒ€é¡ã®æ°Žæº¶æ§åœ¢æ ç©ã䜿çšããããšã§ã
ãã æŽã«æ¬çºæã®å¥ã®ç®çã¯ãåèšãã¿ãã³é¡ãå«
æããè¬å€çµæç©ãæäŸããããšã§ããã æŽã«åãæ¬çºæã®å¥ã®ç®çã¯ãåèšãã¿ãã³ïŒ€
ã®æ°Žæº¶æ§åœ¢æ ç©ã䜿çšããããšã«ããåç©ã«ãã
ãäœã«ã«ã·ãŠã è¡çåã³ã«ã«ã·ãŠã åã³ãªã³ä»£è¬
é害ãæ²»çããæ¹æ³ãæäŸããããšã§ããã 以äžã®èª¬æã«ãã容æã«æãããšãªãããã«ã
ãããåã³ãã®ä»ã®æ¬çºæã®ç®çã¯ãäžèšäžè¬åŒ
ïŒïŒã§è¡šããããåç©ã«ãããã«ã«ã·ãŠã åã³
ãªã³ãã¡ãªã¹ã¿ã·ã¹ãç¶æããããšã«çç©åŠçã«
掻æ§ã§ããåæååç©ãæäŸããããšã«ããéæ
ãããïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãâCH3æãã¯
âCH2CH3ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã
矀ããéžã°ããR1ã¯æ°ŽçŽ æãã¯æ®åºåœãïŒã20
åã®ã°ãªã³ã·ãåäœãå«æããçŽéæãã¯åå²é
ã°ãªã³ã·ãæ®åºã§ããã該R1ã®å°ãªããšãïŒå
ã¯ã°ãªã³ã·ãæ®åºã§ããïŒã çºæãå®æœããããã®æè¯ã®æ æ§ æ¬çºæã¯ãæ確ã«å®çŸ©ããäžã€å®è³ªçã«çŽç²
ãªãç¹æ§ä»ãããããã¿ãã³D3åã³D2ã®åæã®
氎溶æ§åœ¢æ ç©äžŠã³ã«ãããã®ãã¿ãã³é¡ã®ããã
ãã·ã«åèªå°äœãåããŠæäŸãããã®ã§ãããæ¬
çºæã®ååç©ã¯å€ãã®å Žåã«ãããŠçµæ¶æ§ã®ãã®
ã§ããããããã¯åŸæ¥ã®éšåçã«ç²Ÿè£œãããç¹æ§
ä»ãã®è²§åŒ±ãª1αïŒ25âãžããããã·ãã¿ãã³D3
ã®æšå®ããããã°ãªã³ã·ããã«å¯ŸããŠæ確ãªé²æ©
ã瀺ããã®ã§ããã æ¬çºæã®ååç©ã¯äžèšäžè¬åŒïŒïŒãæããã
ã®ã§ããïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãâCH3æãã¯
âCH2CH3ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã
矀ããéžã°ããR1ã¯æ°ŽçŽ æãã¯æ®åºåœãïŒã20
åã®ã°ãªã³ã·ãåäœãå«æããçŽéæãã¯åå²é
ã°ãªã³ã·ãæ®åºã§ããã該R1ã®å°ãªããšãïŒå
ã¯ã°ãªã³ã·ãæ®åºã§ããïŒã ã°ãªã³ã·ãåäœã¯ã°ãªã³ãã©ãã·ã«æãã¯ã°ãª
ã³ãã©ãã·ã«äžŠã³ã«ãããã®ã¢ããç³èªå°äœãæ
å³ãããäžèšã®æ®åºã¯ããããã®ãã¢ããªããŒã
ã©ã³ãã æãã¯äº€äºæãã¯ãããã¯å ±éåäœã§ã
ããã°ãªã³ã·ãåäœã¯ãéé¢ããããã·åºãæã
ã¯
ããäžã§çç©åŠçã«æŽ»æ§ãªäžèšäžè¬åŒã§è¡šãã
ããåæååç©ïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãã¡ãã«æã
ã¯ãšãã«ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã矀
ããéžã°ããR1ã¯ãã°ã«ã³ãŒã¹ããã³ããŒã¹ã
ã¬ã©ã¯ããŒã¹ãã°ããŒã¹ãã¢ããŒã¹ãã¢ã«ãããŒ
ã¹ãã€ããŒã¹ãã¿ããŒã¹ããã©ã¯ããŒã¹ãã¢ã©ã
ããŒã¹ããã·ããŒã¹ãã¹ã¯ããŒã¹ãã»ãããªãŒ
ã¹ããã«ããŒã¹ãã©ã¯ããŒã¹ããã¬ãããŒã¹ãã²
ã³ããªããªãŒã¹ãã¡ãªããªãŒã¹ãã©ãã€ããŒã¹ã
ã²ã³ãã¢ããŒã¹ãâã¢ã»ãã«ââã¬ã©ã¯ããµ
ãã³ãâã¢ã»ãã«ââã°ã«ã³ãµãã³ãâã¢
ã»ãã«ââãã³ããµãã³ãâã¢ã»ãã«ãã€ã©
ãã³é žãâã°ã«ã³ãµãã³ããªããœã·ã«ã¢ãã³ã
ãã³ïŒ€âã¬ã©ã¯ããµãã³ãããªã矀ããéžã°ãã
ã°ãªã³ã·ãã§ãããååç©åœãã®ã°ãªã³ã·ãåäœ
ã®ç·æ°ãïŒä»¥äžã§ããïŒã ïŒ ïŒ£âïŒäœã®çµåãβã§ãããè«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒ ïŒ£âïŒäœã®ïŒžãOR1ã§ããå ŽåãâïŒäœã«
ãããçµåãαã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ã ïŒ ïŒ£â22åã³ïŒ£â23éã®çµåãåäžã§ããã
R2ïŒïŒšã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒ æ¬¡åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ 次åŒã§è¡šãããããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ååç©ïŒ ïŒïŒ R1ãã°ã«ã³ãŒã¹ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ååç©ã ïŒïŒ ååç©ããã¿ãã³D3â3βââã°ã«ã³ã·
ãã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ã25âïŒã°ã«ã³ã·ãïŒâãã¿ãã³D3
ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ãïŒïŒ25âãžããããã· ãã¿ãã³
D3â3βââã°ã«ã³ã·ãã§ãããè«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒïŒ ååç©ã25âããããã· ãã¿ãã³D3â
3βââã°ã«ã³ã·ãã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®ååç©ã ïŒïŒ ååç©ãïŒâããããã·â25âã°ã«ã³ã·ã
âãã¿ãã³D3ã§ãããè«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ååç©ãæçŽ°æž æè¡åé æ¬çºæã¯ãã¿ãã³ïŒ€ã®æ°Žæº¶æ§åæã°ãªã³ã·ãé¡
åã³ã«ã«ã·ãŠã 代è¬ã®å¶åŸ¡ã«ããããã®çšéã«é¢
ããã èæ¯æè¡ ãã¿ãã³D3æ¬ ä¹ãå³ã¡ãã¿ãã³D3ã®ä»£è¬ã«ã
ããé害ã¯ãããç ãè è骚ãžã¹ãããã€ãŒãå
ã³é¢é£ãã骚ç 䞊ã³ã«ãäžè¬çã«ãäœâåã³é«ã«
ã«ã·ãŠã è¡çç¶æ ãªã©ã®ç æ°ãåŒèµ·ãããåŸã€
ãŠããã¿ãã³D3åã³ãã®ä»£è¬ç©è³ªã¯ãè¡æ¶²ã®ã«
ã«ã·ãŠã æ¿åºŠãå¶åŸ¡ããããšã«ãã骚æ§é ã®æ£åžž
ãªçºè²ãç¶æããäžã«æ¥µããŠéèŠã§ããã ãã¿ãã³D3ã¯èèã«ãããŠéãã«25â0HâD3
ã«è»¢æããããäœã«ã«ã·ãŠã è¡çã«å¿çããŠãã
ã¿ãã³ã®äž»ãã埪ç°ä»£è¬ç©ã§ãã25â0HâD3
ã¯ãè èã«ãããŠ1αïŒ25âïŒOHïŒ2D3ã«æŽã«ä»£è¬
ãããã1αïŒ25âïŒOHïŒ2D3ã¯ãD3æãã¯25â
OHâD3ã®ãããããè¿ éã«äœçšãããæŽã«ãã
ã®ãã¿ãã³ã®ãžããããã·åœ¢æ ç©ã¯éçµå£çã«ã
äžã€æ¯æ¥æäžããããªãã°ãçäœå ã§D3ããã
ïŒã10å匷åã§ããããã®ãã¿ãã³ã®ã¢ãããã
ãã·åœ¢æ ãããïŒãïŒå匷åã§ããïŒJ.L.Napoli
åã³H.F.DelucaïŒâBlood Calcium Regulatorsâ
åã³ããã«åŒçšãããŠããæç®ãããŒã¬ãŒ
ïŒBurgerïŒã®ãå»ååŠãïŒMedicinal ChemistryïŒ
第ïŒçã第éšãManfred Wolfç·šãWileyâ
InterscienceïŒ1979幎ã725ã739é ïŒã ãã¿ãã³D2ããã¿ãã³D3æãã¯ïŒïŒïŒïŒ25ïŒ
ïŒïŒ24ïŒ25ïŒ24ïŒ25ïŒ25ïŒ26ïŒæãã¯ïŒïŒ25ïŒ26
ã®äœçœ®ã«ãããŠããããã·ã«åãããŠããããã
ã®ä»£è¬ç©ã¯æ°Žäžæº¶æ§ååç©ã§ãããè¬åãæ°Žæ§ç°
å¢æãã¯èè žç®¡è ã«ãããŠæ¯èŒçäžæº¶æ§ã§ããå Ž
åã«ã¯ãæäžåŸã®æº¶è§£æ§ãè¬ååžåã«ãããåŸé
段éãšãªãåŸããä»æ¹ã氎溶æ§è¬åã«ãããŠã¯ã
溶解ãè¿ éã«èµ·ãããåŸã€ãŠãè¡æ¶²ãéããŠã®æŽ»
æ§éšäœãžã®èŒžéã容æã«ãããåŸã€ãŠã芪氎æ§å
ã³ïŒåã¯æ°Žæº¶æ§ã§ããããªãäžã€æ°Žäžæº¶æ§è¬åã®
æ£åžžãªçç©åŠçç¹æ§ãä¿ã€ãã¿ãã³ïŒ€ïŒD3åã¯
D2ïŒã®åœ¢æ ç©ãæäŸããããšãæãŸããŠããã åã¢ã¡ãªã«ã®æ€ç©Solanum malacoxylonïŒä»¥
äžãS.m.ããšç§°ããïŒã®èããã®æœåºç©ããïŒïŒ
25ïŒHOïŒ2D3ãšç°ãããããŠã°ãªã³ã·ããŒãŒé µçŽ
ã§åŠçãããšïŒïŒ25ïŒOHïŒ2D3åã³æ°Žæº¶æ§æªåå®
æçãçæãã氎溶æ§æåãå«æããŠããããšã
確èªãããŠãããäŸãã°ãM.R.Hausslerçã
Life SciencesïŒ18å·»1049â1056ïŒ1976幎ïŒïŒR.H.
WassermançãScienâce 194å·»ã853â855
ïŒ1976幎ïŒïŒJ.L.NapoliçãThe Journal of
Biologiâcal ChemistryïŒ252å·»ã2580â2583
ïŒ1977幎ïŒãã ã°ãªã³ã·ããŒãŒã§åŠçãããšïŒïŒ25ãžãããã
ã·ãã¿ãã³D3ãçæãã極ããŠé¡äŒŒãã氎溶æ§
æåãCestrum diurnumã以äžãc.d.ããšç§°ã
ãïŒM.R.HughesçãNatureïŒ268å·»ã347â349
ïŒ1977幎ïŒããšããæ€ç©ã«èŠåºãããŠãããããã
ã®S.m.æãã¯C.d.ããã®æ°Žæº¶æ§æœåºç©ã¯1αïŒ25â
ãžããããã·ãã¿ãã³D3ã®ããã«é¡äŒŒããçç©
åŠç掻æ§ãæããã ãããã®æ€ç©ããã®æ°Žæº¶æ§æåã®ã°ãªã³ã·ããŒ
ãŒåŠçã®éã«æŸåºããã氎溶æ§æçã®æ§é ã«é¢ã
ãä»æ¥ãŸã§ã«ååšããå¯äžã®èšŒæ ã¯æå³ã§ããã
åèšåè¡ç©ã®èè çã¯ãé µçŽ ç蚌æ ã氎溶æ§åã³
ååŠæ€åºè©Šè¬ã®äœ¿çšã«åºã¥ããŠããã®æ§é ã¯ãã
ããã°ãªã³ã·ãã§ãããšçµè«ä»ããŠãããN.
Peterlikåã³R.H.WassermanïŒFEBS LettïŒ56
å·»ïŒ16â19ïŒ1973幎ïŒããããããªããããã³ããª
ãŒãºïŒHumphreysïŒãNatureïŒLondonïŒNew
Biology 246å·»ïŒ155ïŒ1973ïŒãã¯ãã¢ãªãã·ãŠ
ïŒMolishïŒçæ°Žåç©è©Šéšããã®æåã«å¯ŸããŠé°æ§
ã§ããããšãå®èšŒãããã®çµè«ã«ã€ããŠçåãæ
ããããã é µçŽ åå¿æŸåºåã®æ°Žæº¶æ§ãã¿ãã³D3å«ææå
ã®ååéã¯ã1000ããçžåœå€§ããããšç¥ãããŠã
ãã®ã§ãD.J.HumphreysïŒNatureïŒLondonïŒ
New Biology 246å·»ïŒ155ïŒ1973幎ïŒããé µçŽ å æ°Ž
å解ã«ããæŸåºããã氎溶æ§è€åæçã®ååéã¯
584ãããçžåœã«å€§ãããšèšç®ããããšãã§ãã
ãžããããã·ãã¿ãã³D3ã®ååéã¯416ã§ããã
ãã®æ§ã«é µçŽ å æ°Žå解ã«ããæŸåºããã氎溶æ§æ
çãäºå®ã°ãªã³ã·ãã§ãããªãã°ãããã¯ãïŒå
ãè¶ããã°ãªã³ã·ãïŒã°ãªã³ãã©ãã·ã«æãã¯ã°
ãªã³ãã©ãã·ã«ïŒåäœãæãããã®ã§ãããã æŽã«ãé µçŽ åå¿æŸåºã®çµæã¯ãåçš®ã®æ§é ãšå
åã«äžèŽãããã®ã§ãããäŸãã°ãM.R.
HausslerçãLife Sciences 18ïŒ1049â1056
ïŒ1976幎ïŒãã¯ãCharonia Iampusã«ç±æ¥ããæ··
åã°ãªã³ã·ããŒãŒãçšããŠãã®æ°Žæº¶æ§æåãå æ°Ž
å解ããããšãé瀺ããŠããããã®é µçŽ ã¯ãçŸå®
ã«ã¯äžèšã®åŠãé µçŽ ã®æ··åç©ã§ããïŒMiles
LaboâratoriesïŒ1977幎ã«ã¿ãã°ïŒïŒÎ²âã°ã«ã³
ã·ããŒãŒïŒ11åäœïŒãαâãã³ãã·ããŒãŒïŒ33å
äœïŒãβâãã³ãã·ããŒãŒïŒ5.2åäœïŒãαâã°ã«
ã³ã·ããŒãŒãβâã°ã«ã³ã·ããŒãŒïŒ4.8åäœïŒãβ
âã¬ã©ã¯ãã·ããŒãŒïŒ44åäœïŒãαâã¬ã©ã¯ãã·
ããŒãŒïŒ26åäœïŒãαâãã³ã·ããŒãŒïŒ24åäœïŒã
βâãã·ãã·ããŒãŒïŒ8.2åäœïŒãβââã¢ã»ã
ã«ã°ã«ã³ãµããããŒãŒïŒ210åäœïŒãαââã¢ã»
ãã«ã¬ã©ã¯ããµããããŒãŒïŒ41åäœïŒãåã³Î²â
âã¢ã»ãã«ã¬ã©ã¯ããµããããŒãŒïŒ25åäœïŒã
ããŒã¿ãŒãªã«ïŒM.PeterlikïŒçãBiochemical
and Biaphysical Research Communicatâions
70å·»ïŒ797â804ïŒ1976幎ïŒãã¯ãã·ã°ãååŠ
ïŒSigma ChemicalïŒç€Ÿè£œã®Î²âã°ã«ã³ã·ããŒãŒ
ïŒã¢ãŒã¢ã³ãïŒãçšããS.m.æœåºç©ã®ç 究ã«ãã
ãŠãæŽã«Î²ââã¬ã©ã¯ãã·ããŒãŒãåã³Î±â
âãã³ãã·ããŒãŒæŽ»æ§ãã·ã°ãååŠç€Ÿã1981幎ïŒ
æã«ã¿ãã°ïŒæŽã«J.SchwartzçArchivâes of
Biochemistry and Biophysiâcsã137å·»ïŒ122â
127ïŒ1970幎ïŒåç §ãããå«æããé µçŽ ãå©çšã
ãã èŠããã«ããããã®èè ã«ãã芳å¯ãããçµæ
ã¯ãåºç¯å²ã®æ§é ã«åèŽãããã®ã§ããããã®ã
ãããè¯ãç¹æ§åä»ããããŠããªãããããšãã°
ãªã³ã·ãé¡ãšèšŒæãããã«ããããã¿ãã³ïŒ€åäœ
åœãå°ãªããšãïŒåãè¶ããã°ãªã³ã·ãåäœãå«
æãããã®ã§ããã åŸã€ãŠãäœã«ã«ã·ãŠã è¡çã«å¯ŸããŠæŽ»æ§ã§ã
ããã«ã«ã·ãŠã åã³ãªã³ã®ãã¡ãªã¹ã¿ã·ã¹
ïŒhomeostaâsisïŒãç¶æãããæ確ã«å®çŸ©ãã
è¯ãç¹æ§ä»ãããããã¿ãã³ïŒ€ã®æ°Žæº¶æ§åœ¢æ ç©ã«
ã€ããŠã®éèŠãåç¶ããŠããã çºæã®é瀺 åŸã€ãŠãæ¬çºæã®ç®çã¯ããã¿ãã³D3ããã¿
ãã³D2åã³ãããã®ããããã·ã«å代è¬ç©ã®è¯
ãç¹æ§ä»ããããæ確ã«å®çŸ©ãããåæ氎溶æ§åœ¢
æ ç©ãæäŸããããšã«ããã æ¬çºæã®ä»ã®ç®çã¯ãäœã«ã«ã·ãŠã è¡çã«å¯Ÿã
ãŠæŽ»æ§ã§ãããåç©äœå ã«ãããŠã«ã«ã·ãŠã åã³
ãªã³ãã¡ãªã¹ã¿ã·ã¹ãç¶æãã掻æ§ãæããåèš
ãã¿ãã³ïŒ€é¡ã®æ°Žæº¶æ§åœ¢æ ç©ã䜿çšããããšã§ã
ãã æŽã«æ¬çºæã®å¥ã®ç®çã¯ãåèšãã¿ãã³é¡ãå«
æããè¬å€çµæç©ãæäŸããããšã§ããã æŽã«åãæ¬çºæã®å¥ã®ç®çã¯ãåèšãã¿ãã³ïŒ€
ã®æ°Žæº¶æ§åœ¢æ ç©ã䜿çšããããšã«ããåç©ã«ãã
ãäœã«ã«ã·ãŠã è¡çåã³ã«ã«ã·ãŠã åã³ãªã³ä»£è¬
é害ãæ²»çããæ¹æ³ãæäŸããããšã§ããã 以äžã®èª¬æã«ãã容æã«æãããšãªãããã«ã
ãããåã³ãã®ä»ã®æ¬çºæã®ç®çã¯ãäžèšäžè¬åŒ
ïŒïŒã§è¡šããããåç©ã«ãããã«ã«ã·ãŠã åã³
ãªã³ãã¡ãªã¹ã¿ã·ã¹ãç¶æããããšã«çç©åŠçã«
掻æ§ã§ããåæååç©ãæäŸããããšã«ããéæ
ãããïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãâCH3æãã¯
âCH2CH3ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã
矀ããéžã°ããR1ã¯æ°ŽçŽ æãã¯æ®åºåœãïŒã20
åã®ã°ãªã³ã·ãåäœãå«æããçŽéæãã¯åå²é
ã°ãªã³ã·ãæ®åºã§ããã該R1ã®å°ãªããšãïŒå
ã¯ã°ãªã³ã·ãæ®åºã§ããïŒã çºæãå®æœããããã®æè¯ã®æ æ§ æ¬çºæã¯ãæ確ã«å®çŸ©ããäžã€å®è³ªçã«çŽç²
ãªãç¹æ§ä»ãããããã¿ãã³D3åã³D2ã®åæã®
氎溶æ§åœ¢æ ç©äžŠã³ã«ãããã®ãã¿ãã³é¡ã®ããã
ãã·ã«åèªå°äœãåããŠæäŸãããã®ã§ãããæ¬
çºæã®ååç©ã¯å€ãã®å Žåã«ãããŠçµæ¶æ§ã®ãã®
ã§ããããããã¯åŸæ¥ã®éšåçã«ç²Ÿè£œãããç¹æ§
ä»ãã®è²§åŒ±ãª1αïŒ25âãžããããã·ãã¿ãã³D3
ã®æšå®ããããã°ãªã³ã·ããã«å¯ŸããŠæ確ãªé²æ©
ã瀺ããã®ã§ããã æ¬çºæã®ååç©ã¯äžèšäžè¬åŒïŒïŒãæããã
ã®ã§ããïŒ ïŒåŒäžãççŽ ïŒ£â22åã³ïŒ£â23éã®çµåã¯åäž
æãã¯äºéçµåã§ãããR2ã¯æ°ŽçŽ ãâCH3æãã¯
âCH2CH3ã§ãããã¯æ°ŽçŽ åã³âOR1ãããªã
矀ããéžã°ããR1ã¯æ°ŽçŽ æãã¯æ®åºåœãïŒã20
åã®ã°ãªã³ã·ãåäœãå«æããçŽéæãã¯åå²é
ã°ãªã³ã·ãæ®åºã§ããã該R1ã®å°ãªããšãïŒå
ã¯ã°ãªã³ã·ãæ®åºã§ããïŒã ã°ãªã³ã·ãåäœã¯ã°ãªã³ãã©ãã·ã«æãã¯ã°ãª
ã³ãã©ãã·ã«äžŠã³ã«ãããã®ã¢ããç³èªå°äœãæ
å³ãããäžèšã®æ®åºã¯ããããã®ãã¢ããªããŒã
ã©ã³ãã æãã¯äº€äºæãã¯ãããã¯å ±éåäœã§ã
ããã°ãªã³ã·ãåäœã¯ãéé¢ããããã·åºãæã
ã¯
ãåŒãïŒR3ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãã¢ãªãŒ
ã«æãã¯ã¢ã©ã«ãã«ã§ããïŒã§ã¢ã·ã«åãããã
ãããã·åºãæããã奜ãŸããã¯ãR3ã¯C1âC6
ã¢ã«ãã«ã§ãããæã奜ãŸããã¯ã¢ã»ãã«æãã¯
ããããªãã«ãããšãã«ããããããšãã«ããã
ããšãã«ãäœçŽã¢ã«ãã«çœ®æããšãã«ãäœçŽã¢ã«
ã³ãã·çœ®æããšãã«ãªã©ãæãã¯ãã³ãžã«ããã
ããã³ãžã«ããããã³ãžã«ãäœçŽã¢ã«ãã«çœ®æã
ã³ãžã«ãäœçŽã¢ã«ã³ãã·çœ®æãã³ãžã«ãªã©ã§ã
ãã äžè¬åŒïŒïŒã®ååç©ãâ22äœã«äºéçµåã
æããå Žåã«ã¯ããããã¯ãã¿ãã³D2ã®èªå°äœ
ã§ããã®ã«å¯Ÿãããã®äœçœ®ã®çµåãåäžã§ããäž
ã€C24ã¢ã«ãã«ããªãå Žåã«ã¯ããããã¯ãã¿ã
ã³D3ã®èªå°äœã§ãããåŸè ã®æ¹ã奜ãŸããã æ¬çºæã®ååç©ã¯ïŒïŒïŒïŒ24ïŒ25æãã¯26äœã«
å°ãªããšãïŒåã®ã°ãªã³ã·ãæ®åºãå«æãããã
ãããªããããããã¯åïŒä»¥äžïŒä»¥äžã®ãã®æ§ãª
ã°ãªã³ã·ãæ®åºãåæã«å«æããŠãããã 奜ãŸããååç©ã¯ããã¿ãã³D3æãã¯D2ïŒïŒ
âããããã·âãã¿ãã³D3æãã¯D2ïŒïŒïŒ25â
ãžããããã·âãã¿ãã³D3æãã¯D2ïŒ25âãžã
ãããã·âãã¿ãã³D3æãã¯D2ïŒ25ïŒ26âãžã
ãããã·âãã¿ãã³D3æãã¯D2ïŒïŒïŒ24ïŒ25â
ããªããããã·âãã¿ãã³D3æãã¯D2åã³ïŒïŒ
25ïŒ26âããªããããã·âãã¿ãã³D3æãã¯D2
ããèªå°ããããã®ã§ããããããã®äžã§æã奜
ãŸãããã®ã¯ãã¿ãã³D3æãã¯D2ïŒïŒâããã
ãã·âãã¿ãã³D3æãã¯D2åã³ïŒâ25âãžãã
ããã·âãã¿ãã³D3æãã¯D2ã§ããã ãã¿ãã³é¡ã®å€ããããã·ã«å圢æ ç©ã®å Žå
ïŒäŸãã°ãïŒïŒ25âãžããããã·âãã¿ãã³D3ã¯
ïŒïŒïŒåã³25äœã«ïŒåã®ããããã·åºãå«æã
ãïŒãæ¬çºæã®å¥œãŸããååç©ã¯ãè€æ°åã®ãã
ããã·åºã®å šéšæªæºã®ãã®ãã°ãªã³ã·ã«åãããŠ
ãããã®ãæã奜ãŸããã¯è€æ°ã®ããããã·åºã®
ïŒåã®ã¿ãã°ã«ã³ã·ã«åãããŠãããã®ã§ããã ãããã®ã°ãªã³ã·ãé¡ã¯20åãŸã§ã®ã°ã«ã³ã·ã
åäœãå«æããããšãã§ãããããããªããã奜
ãŸãããã®ã¯ã10åæªæºãæã奜ãŸããã®ã¯ïŒå
以äžã®ã°ãªã³ã·ãåäœãæãããã®ã§ãããå ·äœ
äŸãšããŠã¯ãã°ãªã³ã·ãæ®åºäžã«ïŒæãã¯ïŒåã®
ã°ãªã³ã·ãåäœãå«æãããã®ãæããããã ã°ãªã³ãã©ããŒã¹æãã¯ã°ãªã³ãã©ããŒã¹ç°æ
ãã¯ãããã®ã¢ããèªå°äœã¯å®å šã«æãã¯éšåç
ã«ã¢ã·ã«åãããŠããŠããããæãã¯å®å šã«è±ã¢
ã·ã«åãããŠããŠããããå®å šæãã¯éšåçã«ã¢
ã·ã«åãããã°ãªã³ã·ãé¡ã¯ãè±ã¢ã·ã«åç©è³ªã®
åæã®ããã®ç¹å®ã®äžéäœãšããŠæçšã§ããã å¯èœæ§ã®ããã°ãªã³ãã©ãã·ã«æ§é ã®äžã«ã¯ã
ã°ã«ã³ãŒã¹ããã³ããŒã¹ãã¬ã©ã¯ããŒã¹ãã°ããŒ
ã¹ãã¢ããŒã¹ãã¢ã«ãããŒã¹ãã€ããŒã¹ãæãã¯
ã¿ããŒã¹ãªã©ãããããã©ãã·ã«æ§é ã®äžã«ã¯ã
奜ãŸãããã®ãšããŠããã©ã¯ããŒã¹ãã¢ã©ãããŒ
ã¹ãã»ãããªãŒã¹ãã¢ã«ããŒã¹ãã©ã¯ããŒã¹ãã
ã¬ãããŒã¹ãã²ã³ããªããªãŒã¹åã³ã¡ãªããªãŒã¹
ããèªå°ããããã®ãæãããããããªã°ãªã³ã·
ãé¡ã®äžã§å¥œãŸãããã®ã¯ããã©ã¯ããŒã¹ãã¢ã©
ãããŒã¹ãæãã¯ãã·ããŒã¹ããèªå°ããããã®
ã§ããã奜ãŸãããžã°ãªã³ã·ãé¡ã®äžã«ã¯ãã¹ã¯
ããŒã¹ãã»ãããªãŒã¹ããã«ããŒã¹ãã©ã¯ããŒ
ã¹ããã¬ãããŒã¹ãã²ã³ããªããªãŒã¹ãåã³ã¡ãª
ããªãŒã¹ãªã©ããããããªã°ãªã³ã·ãé¡ã®äžã§å¥œ
ãŸãããã®ã¯ã©ãã€ããŒã¹ãæãã¯ã²ã³ãã¢ããŒ
ã¹ã§ãããã¢ããèªå°äœã®äžã«ã¯ãâã¢ã»ãã«
ââã¬ã©ã¯ããµãã³ãâã¢ã»ãã«ââã°ã«
ã³ãµãã³ãâã¢ã»ãã«ââã¢ã³ããµãã³ã
âã¢ã»ãã«ãã€ã©ãã³é žãâã°ã«ã³ãµãã³ããª
ããœã·ã«ã¢ãã³ãâã¬ã©ã¯ããµãã³ãªã©ãã
ãã ïŒåãè¶ããã°ãªã³ã·ãåäœãåäžããããã·
åºäžã«ååšããå Žåã«ã¯ïŒå³ã¡ããžæãã¯ããªã°
ãªã³ã·ãæ®åºïŒãåã ã®ã°ãªã³ã·ãç°ã¯ïŒâïŒïŒ
ïŒâïŒïŒïŒâïŒïŒïŒâïŒïŒïŒâïŒæãã¯ïŒâïŒçµ
åã«ãããæã奜ãŸããã¯ïŒâïŒïŒïŒâïŒåã³ïŒ
âïŒã«ããçµåãããŠããŠããããåã ã®ã°ãªã³
ã·ãç°åå¿ã®çµåã¯Î±æãã¯Î²ã§ããã ãã¿ãã³D3æãã¯D2ååã«ä»çãããããã
ã·åºæãã¯ã°ãªã³ã·ãæ®åºã®é žçŽ çµåã®ç«äœé 眮
ã¯Î±ïŒçŽé¢ã®å€åŽïŒæãã¯Î²ïŒçŽé¢ã®å åŽïŒã®ãã
ãã§ãè¯ããïŒâããããã·æãã¯ïŒ£âïŒã«ãã
ãã°ãªã³ã·ããã·åºã®ç«äœé 眮ãβã§ãããç¬ç«
ã«æãã¯åæã«ïŒ£âïŒã®ããããã·æãã¯ã°ãªã³
ã·ããã·åºã®ç«äœé 眮ãαã§ããããšã奜ãŸã
ããåãâ24ã®å»»ãã®ç«äœé 眮ãã§ããã®ã
奜ãŸãããâ24ã«ãããŠãïŒïŒšã§ãããR2
ïŒCH3æãã¯âCH2CH3ã§ããå Žåã«ã¯ãâ24
ã«ãããç«äœé 眮ã¯å¥œãŸããã¯ïŒ³ã§ããã®ãã
ãã æ¬çºæã®ååç©ã®å ·äœäŸãäžèšã«ç€ºãïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²ââã°ã«ã³ãã©ãã·
ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²ââãã©ã¯ããã©ãã·
ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âã»ãããªã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âãã«ãã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âã©ã¯ãã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âãã¬ããã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâã©ãã€ãã·ãïŒ ãã¿ãã³D3ïŒ3βâã²ã³ããªããªã·ãïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²ââ
ã°ã«ã³ãã©ãã·ãïŒïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²ââ
ãã©ã¯ããã©ãã·ãïŒïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²âã»ã«
ããªã·ãïŒïŒ 1αâããããã·â3βâïŒÎ²âãã«ãã·ã«ïŒãã¿
ãã³D3ïŒ 1αâããããã·â3βâã©ãã€ãã·ã«âãã¿ã
ã³D3ïŒ 1αâããããã·â3βâã²ã³ããªããªã·ã«âã
ã¿ãã³D3ïŒ 1αâïŒÎ²ââã°ã«ã³ãã©ãã·ã«ïŒâãã¿ãã³
D3ïŒ 1αâïŒÎ²ââãã©ã¯ããã©ãã·ã«ïŒâãã¿ã
ã³D3ïŒ 1αâïŒÎ²âã»ãããªã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âãã«ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âã©ã¯ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âãã¬ããã·ã«ïŒâãã¿ãã³D3ïŒ 1αâã©ãã€ãã·ã«âãã¿ãã³D3ïŒ 1αâã²ã³ããªããªã·ã«âãã¿ãã³D3ïŒ 1αïŒ25âãžããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²
ââãã©ã¯ããã©ãã·ãïŒïŒ 1αïŒ25âãžããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²
ââã°ã«ã³ãã©ãã·ãïŒïŒ 1αâïŒÎ²ââã°ãªã³ãã©ãã·ã«ïŒâ25âãã
ããã·âãã¿ãã³D3ïŒ 1αâïŒÎ²ââãã©ã¯ããã©ãã·ã«ïŒâ25âã
ãããã·âãã¿ãã³D3ïŒ 1αâããããã·â25âïŒÎ²ââãã©ã¯ããã©
ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âã»ãããªã·ã«ïŒâ
ãã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âãã«ãã·ã«ïŒâã
ã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âã©ã¯ãã·ã«ïŒâã
ã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âãã¬ããã·ã«ïŒâ
ãã¿ãã³D3ïŒ 1αâããããã·ã25âã©ãã€ãã·ã«âãã¿ã
ã³D3ïŒ 1αâããããã·ã25âã²ã³ããªãã·ã«âãã¿
ãã³D3ã äžèšèªå°äœã®å šãŠã¯åããã¿ãã³D2ãçšããŠ
調補ããããšãã§ããã æ¬çºæã®ãã¿ãã³ïŒ€é¡ã®ã°ãªã³ã·ãèªå°äœã¯åœ
æ¥è ã«å ¬ç¥ã®æšæºçåææ¹æ³ã«ãã調補ããããš
ãã§ããããããã®æ¹æ³ã¯åºçºãã¿ãã³D3æã
ã¯D2ãïŒä»¥äžã®ããããã·åºãå«ããåŠãã«ã
ã€ãŠç°ãããã¿ãã³ãå¯äžã®ããããã·åºãæã
ãå Žåã«ã¯ãåæã¯ç°¡åã§ãããå³ã¡ãã¢ããã
ããã·ã«åãã¿ãã³ïŒïŒäœã§ããããã·ã«åïŒã
ãã³ãŒã³æãã¯ãã«ãšã³ãªã©ã®äžæŽ»æ§ãªé極æ§æº¶
åªã®éæµæº¶æ¶²äžã«ãããŠçé žéã§åŠçããããã«
æ«ç«¯ç°ïŒå³ã¡ãæè¬åäžç°ïŒã®ïŒ£â1â²äœã«ãããŠ
é©åœãªé¢è±åºïŒL.G.ïŒãæããå®å šã«ã¢ã·ã«åã
ããã°ãªã³ã·ãæãã¯å®å šã«ã¢ã·ã«åãããçŽé
æãã¯åå²éã°ãªã³ã·ãããªããŒãæ·»å ããã次
ã®åå¿ã«åŸã€ãŠçž®åãèµ·ããããããã§ã¯äŸç€ºã®
ã¿ãç®çãšããŠåäžã°ãªã³ã·ãã«ã€ããŠã®ã¿ç€ºã
ããŠããïŒ ãã®åå¿ç³»åã«ãããŠãR3ã¯åèšã®éãã§ã
ããLGã¯ïŒååæ±æ žçœ®æåå¿ã«ãããŠçœ®æãã
ãããšã®ã§ããèçŽ ãå¡©çŽ ããšãŠçŽ ãïœâãã«ãš
ã³ã¹ã«ããã«ãªã©ã®éåžžã®é¢è±åºã§ããã ãã¿ãã³D3æãã¯D2ãã°ãªã³ã·ãããªããŒãš
åå¿ãããå Žåã«ã¯ãã°ã«ã³ãã©ãã·ãæãã¯ã°
ãªã³ãã©ãã·ãç°äžã®ïŒå以äžã®OCOR3åºã¯ã
ã°ãªã³ã·ãåäœã®ç·æ°ã20ãè¶ããªãããšãæ¡ä»¶
ãšããŠãå®å šã«ã¢ã·ã«åãããã°ãªã³ã·ãåäœã§
眮æãããã åå¿ã¯å®€æž©ä¹è³éæµæ¡ä»¶ã«ãããŠïŒã10æéè¡
ãªãããã®åŸå·åŽåã³éããŠéå¡©ãé€å»ããã
液ã也ç¥ããäžæŽ»æ§æº¶åªãçå»ãããåŸããã
çæç©ãé«æ§èœæ¶²äœã¯ãããã°ã©ãã€ãŒãã±ã€é ž
ã¯ãããã°ã©ãã€ãŒãèå±€äºåã¯ãããã°ã©ãã€
ãŒãªã©ã®æšæºçãªè¿ä»£ç粟補æ¹æ³ã®ä»»æã®ãã®ã«
ãã粟補ããããšãã§ãããéåžžäºã€ã®çæç©ã®
æ··åç©ãåŸããããããã¯ç°çµåç¹ã«ãããαå
ã³Î²ã°ãªã³ãã©ãã·ã«æãã¯ã°ãªã³ãã©ãã·ã«èª
å°äœã§ããããããã¯éåžžäžèšã¯ãããã°ã©ãæ³
ã«ããåé¢ããããšãã§ããã åã ã®çæç©ãåé¢åŸãã°ãªã³ã·ãæ®åºã¯ãã¡
ã¿ããŒã«äžãããªãŠã ã¡ããã·ãæãã¯ã¡ã¿ããŒ
ã«äžã¢ã³ã¢ãã¢ãªã©ã®å¡©åºå ã«ãããŠè±ã¢ã·ã«å
ãããæŽã«é«æ§èœã¯ãããã°ã©ãã€ãŒã«ãã粟補
ãéåžžè¡ããé«åºŠã«ç²Ÿè£œãããçæç©ãåŸãã åºçºãã¿ãã³ïŒ€ïŒD3æãã¯D2ïŒãïŒåã®ããã
ãã·åºïŒäŸãã°ãïŒâããããã·ãã¿ãã³D3ã
æãã¯25âããããã·ãã¿ãã³D3ïŒãæããå Ž
åã«ã¯ããããã®äžã€ã¯ãçž®ååŸäžã€ã°ãªã³ã·ã
æ®åºã®è±ã¢ã·ã«ååãäžãæãã¯åŸã«æçµçã«ã¯
é€å»ããããšã®ã§ããä¿è·åºã§éžæçã«ä¿è·ãã
ãå¿ èŠããããããã¯ïŒå以äžã®ããããã·åºã
ãã¿ãã³åºçºç©è³ªäžã«ååšããå Žåã«ãããŠã¯ãŸ
ãããããã®å ã®å šéšæªæºã®ãã®ãã°ãªã³ã·ã«å
ãããããšãå¿ èŠãšããã åºçºç©è³ªäžã®ããããã·åºã®éžæçä¿è·ã¯ãæ
æ©ååŠã®åœæ¥è ã«åšç¥ã®æšæºçä¿è·åã³è±ä¿è·å
å¿ãçšããŠè¡ãããšãã§ããã ãã¿ãã³ïŒ€ååäžã®åããããã·åºã¯ãããã
äžçŽïŒäŸã26âOHïŒãäºçŽïŒäŸã24âOHã3βâ
OHãªã©ïŒæãã¯äžçŽïŒäŸã25âOHïŒã®ããã
ãã·ã«å®èœåºã®ããããã§ãããšããäºå®ã«ãã
ç°ã€ãåå¿æ§ãæããã®ã§ãéžææ§ãéæããã
ãšãã§ãããæŽã«ãç«äœçèæ ®ã«ããã3βâOH
ã¯ãé£æ¥ããããã·ã«å®èœåºã§ãããšå ±ã«C10äž
ã®ç°å€C19ã¡ãã¬ã³å®èœåºã«ãã€ãŠç«äœçã«åŠšã
ãããŠãã1αâOHãšã¯ç°ã€ãåå¿æ§ãæããã
ãããã®åå¿æ§ã®å¥œäŸã¯ããªãã¯ïŒHolickïŒç
ã«ãããBiochemistryïŒ10å·»ã2799ïŒ1971幎ã«
äŸç€ºãããŠããããã®æç®ã«ã¯ãïŒïŒ25âïŒOHïŒ
2âD3ã®ããªã¡ãã«ã·ãªã«ãšãŒãã«èªå°äœãHC1
âMeOHäžã«ãããŠæž©åãªæ¡ä»¶äžã«ããããã·
ã«åããŠïŒïŒ25âïŒOHïŒ2âD3ã®ïŒïŒ25âãžã·ãª
ã«ãšãŒãã«åã³25âã¢ãã·ãªã«ãšãŒãã«èªå°äœã
åŸãããšãã§ããããšã瀺ãããŠãããæŽã«ãïŒ
åã³ïŒã®ããããã·ã«ãä¿è·ãããŠããïŒïŒ25â
ïŒOHïŒ2âD3ãåŸãããã«ã¯ãïŒïŒ25âïŒOHïŒ2â
D3ã®25âã¢ãã·ãªã«ãšãŒãã«èªå°äœãã¢ã»ãã«
åããŠïŒïŒ25âïŒOHïŒ2âD3âïŒïŒïŒâãžã¢ã»ã
ã«â25âããªã¡ãã«ã·ãªã«ãšããŒã«ã圢æããã
ãšãã§ãããã¢ã»ããŒãé¡ã¯é žå æ°Žå解ã«å¯ŸããŠ
極ããŠå®å®ã§ããã®ã§ããã®èªå°äœãé žå æ°Žå解
ããŠïŒïŒïŒâãžã¢ã»ããã·â25âããããã·ãã¿
ãã³D3ãåŸãããšãã§ããã代æ¿çææ³ã¯åã«
ïŒïŒ25âïŒOHïŒ2âD3ãããªãžã³äžã®ç¡æ°Žé ¢é žäž
ã«ãããŠå®€æž©ã§24ã48æéã¢ã»ãã«åããŠïŒïŒïŒ
âãžã¢ã»ããã·â25âããããã·ãã¿ãã³D3ã
åŸãããšã§ãããã 25âããããã·ãã¿ãã³D3ã«å¯ŸããŠ25âãã
ããã·ã«åºãä¿è·ããããã«ã¯ã次ã®ããšãè¡ã
ããšãã§ããïŒå³ã¡ã25âOHâD3ã¯ç¡æ°Žé ¢é žå
ã³ããªãžã³äžã«ãããŠéæµæ¡ä»¶äžã«24æéã§å®å š
ã«ã¢ã»ãã«åããããšãã§ãããïŒâAcã¯å®€æž©
ã«ãããŠ12æéã±ã³åïŒ95ïŒ MeOHâæ°Žäžã®
KOHïŒã«ããéžæçã«é€å»ããããšãã§ããã äžåºŠææã®ä¿è·ãã¿ãã³ïŒ€èªå°äœã調補ããã
ãšããããçé žéãšåå¿ããããäžèšåå¿åŒã®
åŠãã°ãªã³ã·ãæãã¯ããªã°ãªã³ã·ãæ®åºãšåå¿
ããã次ãã§è±ã¢ã·ã«åãè±ä¿è·åºåã³ç²Ÿè£œãè¡
ããçé žé以å€ã®ãã®ãçšããæ¹æ³ãæ¡çšã§ãã
äŸãã°ãK.IgaraâshiãâAdvances in
Carbohydrate Chemistry and Biochemistryâ
34å·»ã243â283ãæãã¯C.D.WarrençCarbohâ
ydrate Researchã82å·»ïŒ71â83ïŒ1980幎ïŒã®èš
èŒãæããããšãã§ããã 容æã«å©çšå¯èœãªåºçºãã¿ãã³ïŒ€èªå°äœãšããŠ
ã¯ãäžèšã®ãã®ãæããããïŒ ãã¿ãã³D3ïŒ ãã¿ãã³D2ïŒ ïŒâããããã·âãã¿ãã³D3ïŒ ïŒâããããã·âãã¿ãã³D2ïŒ 25âOHâãã¿ãã³D3ïŒ 25âOHâãã¿ãã³D2ïŒ ïŒïŒ24âïŒOHïŒ2âãã¿ãã³D3ïŒ ïŒïŒ25âãžããããã·âãã¿ãã³D3ïŒ ïŒïŒ25âãžããããã·âãã¿ãã³D2ïŒ 24ïŒ25âãžããããã·âãã¿ãã³D3ïŒ 25ïŒ26âãžããããã·âãã¿ãã³D3ïŒ 24ïŒ25âãžããããã·âãã¿ãã³D2ïŒ ïŒïŒ24ïŒ25âããªããããã·âãã¿ãã³D3ïŒ ïŒïŒ25ïŒ26âããªããããã·âãã¿ãã³D3ã ããçš®ã®ç©è³ªãäŸãã°ã25ïŒ26âãã¿ãã³D2ïŒ
ïŒïŒ24ïŒ25âããªããããã·ãã¿ãã³D2æãã¯
ïŒïŒ25ïŒ26âããªããããã·ãã¿ãã³D2ã¯åœå
éã«ãããŠæªã ååã«åå®ãããŠããªããããã
ããåæçã«èª¿è£œããããªãã°äœ¿çšããããšãå¯
èœã§ããã 第äžïŒæãã¯å¯äžïŒã®ã°ãªã³ã·ãç°ã®ïŒ£â1â²äœ
ã«é¢è±åºãæããã¢ã·ã«åã°ãªã³ã·ãã¯ãäŸã
ã°ããã¬ããã€ãŒïŒH.G.Fletcher Jr.ïŒã®
âMethodsin Carbohydrate ChemistryâïŒå·»ïŒ
228ïŒ1963幎ïŒæãã¯ãããŒïŒW.A.BonnerïŒã®
âJournal of Organic Chemistryâ26å·»ïŒ908â
911ïŒ1961幎ïŒãæãã¯ã«ããŠãŒïŒR.U.LemieuxïŒ
ã®âMethods in Carbâohydrate Chemistryâã
第巻ã221ïŒ222ã«èšèŒãããŠããæ¹æ³ã«ãã調
補ããããšãã§ããã ãªãªãŽãµãã«ã©ã€ãäžéäœã¯ãäŸãã°ãã«ããŠ
ãŒãR.U.LemieuxãJ.of Amer.Chem.Soc.97
å·»ïŒ4063â4069ïŒ1975幎ïŒãããã¬ã·ãšãããJ.M.
J.FrechetïŒâPolymerâSuppoârted Reactions
in Organic SynthâesisâïŒ1980幎ïŒ407â434ãã
æãã¯ã±ããã€ãJ.F.KennedyãâCarbohydrate
CheâmistryâïŒå·»ïŒ496â585ïŒ1975幎ïŒãã®æ¹æ³
ã«ãã調補ããããšãã§ããã åžè²©ã®ç³é¡ãšããŠã¯æ¬¡ã®ãã®ãæãããã
ïŒPfaânstiehl LaboratoriesïŒIncïŒïŒïŒãã³ããŒ
ã¹é¡ãäŸãã°ãâã¢ã©ãããŒã¹ãâã¢ã©ãã
ãŒã¹ãâãªããœãŒã¹ãâãªããœãŒã¹ãâãª
ããŒã¹ãâãã·ããŒã¹ãâãã·ããŒã¹ãªã©ã
ãããœãŒã¹é¡ãäŸãã°ãããã¹ãããŒã¹ãâã
ã©ã¯ããŒã¹ãâã¬ã©ã¯ããŒã¹ãαââã°ã«ã³
ãŒã¹ãβââã°ã«ã³ãŒã¹ãâã°ã«ã³ãŒã¹ãã¬
ãããŒã¹ãâãã³ããŒã¹ãâãã³ããŒã¹ã
âãœã«ããŒã¹ãªã©ãããããŒã¹é¡ãäŸãã°ãâ
ã°ã«ã³ããããŒã¹ãâãã³ããããããŒã¹ãã»
ãããããã¶ã³ãªã©ããžãµãã«ã©ã€ãé¡ãäŸã
ã°ãã»ãããªãŒã¹ãïŒââβââã¬ã©ã¯ãã
ã©ãã·ã«ââã¢ã©ãããŒã¹ãã²ã³ããªããªãŒ
ã¹ãã©ã¯ããŒã¹é¡ãαâã©ã¯ãããŒã¹ããã«ããŒ
ã¹ãαâã¡ãªããªãŒã¹ãã¹ã¯ããŒã¹ããã¬ãããŒ
ã¹ããã©ããŒã¹ãªã©ãããªãµãã«ã©ã€ãé¡ãäŸã
ã°ãã¡ã¬ãããŒã¹ãã©ãã€ããŒã¹ãªã©ãããã©ãµ
ãã«ã©ã€ãé¡ãäŸãã°ãã¹ã¿ããªãŒã¹ãªã©ãããª
ãµãã«ã©ã€ãé¡åã³ãã®èªå°äœãäŸãã°ãã¢ã©ã
ã³é žãããã€ã³ãããã¶ã³ãããã¹ããªã³ãã·ã¯
ãâããã¹ããªã³é¡ãã°ãªã³ãŒã²ã³ãã€ããªã³ãª
ã©ã æãã¯åãå šåæçµè·¯ïŒä¿è·ãçž®ååã³è±ä¿
è·ïŒããããã¿ãã³ïŒ€ã§ããÎ5,7ã¹ããã€ããžãš
ã³ãåºçºç©è³ªãšããŠçšããŠè¡ãããšãã§ãããã°
ãªã³ã·ã«ååŸããã®ãããã¿ãã³ãå ååŠçã«é
ç°ããåŸããããããã¿ãã³ãç±çã«åé åããŠ
ã°ãªã³ã·ã«åãã¿ãã³ãåŸãã ãã¿ãã³ïŒ€ã®æŽ»æ§åœ¢æ ç©ã¯ãïŒïŒ25âãžããã
ãã·ãã¿ãã³D3ã§ããããšãç¥ãããŠããããJ.
L.Napoliåã³H.F.DeLucaïŒâBurger's
Medicinal Chemistryâ第ïŒçã第éšã728ff
é ããïŒïŒ25âãžããããã·âãã¿ãã³D3ã°ãªã³
ã·ããäœã«ã«ã·ãŠã è¡çç¶æ ã®æ²»çã«æãã¯å
ç©ãç¹ã«ããã«ããããªã³åã³ã«ã«ã·ãŠã 代è¬ã®
å¶åŸ¡ã«äœ¿çšãããå Žåã«ã¯ãåç©ã®å å æ§ã°ãªã³
ã·ããŒãŒé µçŽ ãçŽæ¥çã«ãã®ãã¿ãã³ã®æŽ»æ§åœ¢æ
ç©ãæŸåºãããä»æ¹ããã®ãã¿ãã³ã®éãããã
ã·ã«åèªå°äœã䜿çšãããå Žåã«ã¯ïŒäŸãã°ãã
ã¿ãã³D3ã°ãªã³ã·ãïŒãããããã·ã«åãã¿ãã³
ã®é µçŽ ã«ããæŸåºã«ç¶ããŠã掻æ§ïŒïŒ25âãžãã
ããã·ãã¿ãã³ã圢æããããã«ãèèã次ãã§
è èã«ãããŠããããã·ã«åãè¡ãããã æ¬çºæã®æ°Žæº¶æ§ã°ãªã³ã·ã«åãã¿ãã³ïŒ€è€åäœ
ã¯ã芪氎æ§ã®è¯å¥œãªæ°Žæº¶æ§èªå°äœä¹è³åªãã氎溶
æ§ã®èªå°äœãå å«ããããããã¯ãäžè¬çã«ãåŸ
æ¥ãã¿ãã³D3ããã¿ãã³D2æãã¯ãããã®ãã
ããã·ã«åèªå°äœãå¿ èŠãšãããŠããä»»æã®çšé
ã«äœ¿çšããããšãã§ãããæ¬çºæã®è€åäœã®å©ç¹
ã¯ããããã®æ°Žæº¶æ§ã«ãããåŸã€ãŠãäŸãã°ãå¡©
æ°Žæãã¯æ°Žæ§ç·©è¡æ¶²ã®ãããªæ°Žæ§åªäœã«ãããæ
äžã®å®¹ææ§ã«ãããããã¯ããããã®è€åäœãã
ã¿ãã³ïŒ€æŸåºã€ã³ã©ã€ã³ãã³ããéèå åé åšãª
ã©ã®è£ 眮ã«ãããŠå©çšããããšãå¯èœã«ãããã
ã®ä»ã®å©ç¹ãšããŠã¯ãèèªæªåžåçå矀ã®æ²»ç䞊
ã³ã«è žã«ãããçç©åŠçã«æŽ»æ§åœ¢æ ã®ãã¿ãã³
D3ã®æŸåºãäŸãã°ãïŒïŒ25âïŒOHïŒ2âD3ã°ãªã³
ã·ãâè žâïŒïŒ25âïŒOHïŒ2âD3âçç©åŠçäœçš
ãªã©ãæããããã æ¬çºæã®è€åäœã¯ãåç©ãç¹ã«ããã«ãããã«
ã«ã·ãŠã åã³ãªã³ã®ãã¡ãªã¹ã¿ã·ã¹åã³ä»£è¬ã®å¶
埡ãè¡ãä»»æã®æ段ã«ããæäžããããšãå¯èœã§
ãããäŸãã°ãæäžã¯å±æçãéçµå£çãç®äžã
ç®å ãéèå ãçèå æãã¯è ¹è å ã«è¡ãããšã
ã§ãããããããšã¯å¥ã«ãæãã¯åæã«ãæäžã¯
çµå£çã«è¡ãããšãã§ãããæäžéã¯ãå容è ã®
幎什ãå¥åº·åã³äœéãåæã«è¡ãããæ²»çã®çš®
é¡ãæ²»çã®é »åºŠåã³ææãšãããå¹æã®æ§è³ªã«å¿
ããŠç°ããäžè¬çã«ã¯ã掻æ§æåååç©ã®æäžé
ã¯äœéKgåœãçŽ0.1ÎŒïœãïŒmgã§ãããéåžžãææ
ã®çµæãåŸãããã«ã¯ãæ²»çã®ããã®ïŒå以äžã®
æœçšã«ãããŠãæœçšåœã0.1ÎŒïœã10ÎŒïœïŒKgãæ
å¹ã§ããã æ¬çºæã®ååç©ã®æŽã«äºæ³å€ã®æ§è³ªã¯ãããã
ã®ãããã®ãã骚ããã®ã«ã«ã·ãŠã æŸåºã«ããã
ãããããã«ã«ã·ãŠã åå¡ãèµ·ããããšãªãè žã
éããŠã®ã«ã«ã·ãŠã åžåã®ä¿é²ã瀺ãããšã§ã
ãã骚æŸåºã«ããã«ã«ã·ãŠã åå¡ã¯ãïŒïŒ25âãž
ããããã·ãã¿ãã³D3ã®å ±éã®ç¹åŸŽã§ãããæ¬
çºæã®ååç©ã®ãããã®ã«ãããããã®éžæçäž
ååšã¯ãè žã®ã«ã«ã·ãŠã 茞éãåºæããããšã«ã
ã€ãŠè¡æž ã«ã«ã·ãŠã æ¿åºŠã®å¢å€§ãä¿é²ããããšã«
ãã奜ãŸããæ²»ççµæããããããéã骚ã®ç ã
æããæ£è ã«ãšã€ãŠã圌çã®æ¢ã«æ¶èãã骚ãã
ã®ã«ã«ã·ãŠã ãåå¡ãããšããç ç²ã«ãã€ãŠè¡æž
ã«ã«ã·ãŠã æ¿åºŠãç¶æããããšã¯äžå©ãªããšã§ã
ãã æ¬çºæã®ååç©ã¯ãçµå£æäžçšã«ãé å€ãã«ã
ã»ã«ãç²æ«å æãã¯æ¶²äœæº¶æ¶²ãæžæ¿æ¶²æãã¯ãšãª
ãã·ã«ãªã©ãæãã¯éçµå£çšéã®ããã«ã溶液æ
ãã¯æžæ¿æ¶²ãªã©ã®ç¡è調å€æ¶²ã®æäžåœ¢æ ã§äœ¿çšã
ãããšãã§ããããã®æ§ãªçµæç©ã«ãããŠã掻æ§
æåã¯ãéåžžãçµæç©ã®å šééã®å°ãªããšãïŒÃ
10-6ééïŒ ãããã90ééïŒ ä»¥äžã®éã§åžžã«ååš
ãããäžæŽ»æ§ãªè¬åŠçã«èš±å®¹å¯èœãªæ äœã䜿çšã
ãã®ã奜ãŸããããã®æ§ãªæ äœãšããŠã¯ã95ïŒ ãš
ã¿ããŒã«ãæ€ç©æ²¹ããããã¬ã³ã°ãªã³ãŒã«é¡ãå¡©
æ°Žç·©è¡æ¶²ãªã©ãå«ãŸããã 以äžãäžè¬çã«æ¬çºæã説æããããç¹å®ã®å ·
äœäŸãåç §ããããšã«ããæŽã«å®å šã«ç解ããã
ãšãã§ããããããã®äŸã¯äŸç€ºã®ã¿ãç®çãšããŠ
瀺ããããã®ã§ãããç¹ã«æãã®ãªãéããæ¬çº
æãéå®ãã趣æšã®ãã®ã§ã¯ãªãã äŸ ïŒ ãã¿ãã³D3ïŒ3βâã°ãªã³ã·ãã®èª¿è£œ èœäžæŒæåã³èžçé éšãä»å±ãã100mlã®äžã€
éŠäžžåºãã©ã¹ã³å ã«ãããŠã147mgïŒ0.382ããªã¢
ã«ïŒã®ãã¿ãã³D3ã溶解ããã5mlã®ä¹Ÿç¥ãã³ãŒ
ã³äžã«ããã«ãŒïŒBeckerïŒãBiochem.Biophys.
ActïŒ100ïŒ574â581ïŒ1965ïŒãã®æ¹æ³ã«åŸã€ãŠæ°
ããã«èª¿è£œããã1.00ïœïŒ3.63ããªã¢ã«ïŒã®ä¹Ÿç¥
çé žéãæžæ¿ãããããã®æº¶æ¶²ã沞ãšããããã
ãã®æç¹ã«ãããŠã25mlã®ãã³ãŒã³ã«æº¶è§£ãã
äžèšã¬ããŠãŒïŒLemieuxïŒã®æ¹æ³ã«åŸã€ãŠèª¿è£œ
ããã647mgïŒ1.57ããªã¢ã«ïŒã®ããã©ââã¢
ã»ãã«âβââã°ã«ã³ãã©ãã·ã«ãããã€ãã
滎äžããããã³ãŒã³ã®èžçãç¶ç¶ããçŽ1/2æé
åŸã«æŽã«çé žéïŒçŽ1gïŒãåå¿æ¶²ã«æ·»å ããã
åå¿åŸãèå±€ã¯ãããã°ã©ãã€ãŒïŒ20ïŒ80vïŒïœ
é ¢é žãšãã«ïŒãããµã³ïŒãè¡ã€ããåŸããçæç©
ã¯0.24ã®Rfãæããäž»ããçæç©ã¯0.20ã®Rfãæ
ãããïŒæéåŸã«åå¿æ¶²ãå·åŽããã¬ã©ã¹ãŠãŒã«
ãéããŠéããŠéå¡©ãé€å»ããã液ãç¡æ°Žç¡«
é žãããªãŠã äžã§ä¹Ÿç¥ãããã³ãŒã³ãçªçŽ äžã«ç
å»ãããåŸããé»è²æ²¹ãäºåÎŒâPorasilé«å§æ¶²
äœã¯ãããã°ã©ãã«ã©ã ïŒå¯žæ³ïŒmmÃ30cmãæµé
2mlïŒåã溶åª15/85ïœïŒïœé ¢é žãšãã«ïŒãããµ
ã³ïŒã«ããããäž»ããçæç©ãïŒïŒ10âã»ã³ã³ã¬
ã¹ã¿âïŒïŒïŒïŒ10ïŒ19ïŒâããªãšã³â3βâã€ã«â
2â²ïŒ3â²ïŒ4â²ïŒ6â²âããã©ââã¢ã»ãã«âβâ
âã°ã«ã³ãã©ãã·ãã®ä¿ææéã¯58åã§ãããã
ã¿ãã³ïŒ€äžã®ããªãšã³çºè²å£ã«ç¹æ§çãª265nmã®
æ倧åžå 床åã³228nmã®æå°åžå 床ã瀺ãããã
ã®è³ªéã¹ãã¯ãã«ã¯èŠªååã€ãªã³ã®ããŒã¯ãïœïŒ
e714ïŒ2.5ïŒ ïŒM+ïŒã«å«ã¿ãããŒã¯ã383ïŒïŒïŒ
ïŒïŒâããããŠã ã€ãªã³ïŒïŒ366ïŒ28ïŒ ïŒïŒâãã
ããŠã ã€ãªã³âæ°ŽïŒ+ïŒ351ïŒ18ïŒ ïŒ331ïŒ15ïŒ ïŒã
ãããŠã ã€ãªã³ïŒ+ïŒ271ïŒ2.5ïŒ ïŒ253ïŒ14ïŒ ïŒ
169ïŒ100ïŒ ïŒïŒC8H9O4ïŒ+ïŒ109ïŒ63ïŒ ïŒC6H5O2ïŒ
ïŒïŒåã³60ïŒ20ïŒ ïŒã®é žã¡ãã«æãã¯é ¢é žïŒã«äœ
ã€ããåŸããçæç©ãïŒïŒ10âã»ã³ã³ã¬ã¹ã¿â
ïŒïŒïŒïŒ10ïŒ19ïŒâããªãšã³â3βâã€ã«â2â²ïŒ3â²ïŒ
4â²ïŒ6â²âããã©ââã¢ã»ãã«âαââã°ã«ã³
ãã©ãã·ãã®ä¿ææéã¯45åã§ãããå265nmã«
ãããæ倧åžå 床åã³228nmã«ãããæå°åžå 床
ã瀺ããããã®è³ªéã¹ãã¯ãã«ã¯ïœïŒe714ã®åå
ã€ãªã³ã瀺ããã 58åã®ä¿ææéãæããäž»ããçæç©ã次ãã§
ãããªãŠã ã¡ããã·ãåã³ã¡ã¿ããŒã«ãçšããŠè±
ã¢ã·ã«åãããç¡æ°Žã¡ã¿ããŒã«äžã«æº¶è§£ããåå
ç©ã«ãããªãŠã éå±ã®å°çãæ·»å ããã1/2æé
åŸæº¶æ¶²ãçšé ¢é žã§äžåããããã®æº¶æ¶²ãçªçŽ äžã«
也ç¥ãã次ãã§éçžé«å§æ¶²äœã¯ãããã°ã©ãã«ã©
ã ïŒRadial PakA column Waters AssociatesïŒ
寞æ³0.8Ã10cmãæµé1mlïŒåã溶åª98/2ïœïŒïœã¡
ã¿ããŒã«ïŒæ°ŽïŒã«ããããçæç©ãïŒïŒ10âã»ã³
ã³ã¬ã¹ã¿âïŒïŒïŒïŒ10ïŒ19ïŒããªãšã³â3βâã€ã«
âβââã°ã«ã³ãã©ãã·ãã®ä¿ææéã¯12.5å
ã§ããããã¿ãã³ïŒ€çºè²å£ã«å žåçãªÎ»nax
265nmãλnio228nmã®UVã¹ãã¯ãã«ã瀺ããã ãã¿ãã³D3ïŒ3βâã°ã«ã³ã·ãããã¿ãã³D3ïŒ
3αâã°ã«ã³ã·ãåã³ãã¿ãã³D3ïŒ3βã°ã«ã³ã·ã
ã¢ã»ããŒãã®çç©åŠç掻æ§ã®è©Šéšãè¡ã€ãã
Holtzmann瀟ïŒç±³åœããŠã€ã¹ã³ã³ã·ã³å·ã
MadisonïŒããåŸãããéã®ä¹³é¢ãããã°ããã®
ã©ããã«ãªã³ã¯é©æ§ã§ãããã«ã«ã·ãŠã ã®äœã
ïŒ0.02ïŒ ïŒãã¿ãã³ïŒ€æ¬ ä¹ã®é£é£ŒãïŒâ1/2é±éäž
ãããïŒå¹ã®åç©çŸ€ã«çµå£çã«4ÎŒïœã1ÎŒïœã0.5ÎŒ
ïœã0.25ÎŒïœãã¿ãã³D3â3βâã°ã«ã³ã·ãã1ÎŒïœ
ã®ãã¿ãã³D3â3αâã°ã«ã³ã·ãæãã¯2ÎŒïœã®ã
ã¿ãã³D3â3βâã°ã«ã³ã·ãã¢ã»ããŒãã50ÎŒlã®
95ïŒ ãšã¿ããŒã«ã«æº¶è§£ãããã®æãã¯çšéå€åç¬
ãæäžããã24æéåŸã«åç©ã殺ããå°è žåã³è¡
液ãéãããè žã«ã«ã·ãŠã 茞éç 究ãè£è¿ãè žè¢
æè¡ã«ããè¡ããè¡æ¶²ã¯è¡æž ã«ã«ã·ãŠã 枬å®ã«äœ¿
çšãããçµæãäžè¡šã«ç€ºãã
ãããã·åºãæããã奜ãŸããã¯ãR3ã¯C1âC6
ã¢ã«ãã«ã§ãããæã奜ãŸããã¯ã¢ã»ãã«æãã¯
ããããªãã«ãããšãã«ããããããšãã«ããã
ããšãã«ãäœçŽã¢ã«ãã«çœ®æããšãã«ãäœçŽã¢ã«
ã³ãã·çœ®æããšãã«ãªã©ãæãã¯ãã³ãžã«ããã
ããã³ãžã«ããããã³ãžã«ãäœçŽã¢ã«ãã«çœ®æã
ã³ãžã«ãäœçŽã¢ã«ã³ãã·çœ®æãã³ãžã«ãªã©ã§ã
ãã äžè¬åŒïŒïŒã®ååç©ãâ22äœã«äºéçµåã
æããå Žåã«ã¯ããããã¯ãã¿ãã³D2ã®èªå°äœ
ã§ããã®ã«å¯Ÿãããã®äœçœ®ã®çµåãåäžã§ããäž
ã€C24ã¢ã«ãã«ããªãå Žåã«ã¯ããããã¯ãã¿ã
ã³D3ã®èªå°äœã§ãããåŸè ã®æ¹ã奜ãŸããã æ¬çºæã®ååç©ã¯ïŒïŒïŒïŒ24ïŒ25æãã¯26äœã«
å°ãªããšãïŒåã®ã°ãªã³ã·ãæ®åºãå«æãããã
ãããªããããããã¯åïŒä»¥äžïŒä»¥äžã®ãã®æ§ãª
ã°ãªã³ã·ãæ®åºãåæã«å«æããŠãããã 奜ãŸããååç©ã¯ããã¿ãã³D3æãã¯D2ïŒïŒ
âããããã·âãã¿ãã³D3æãã¯D2ïŒïŒïŒ25â
ãžããããã·âãã¿ãã³D3æãã¯D2ïŒ25âãžã
ãããã·âãã¿ãã³D3æãã¯D2ïŒ25ïŒ26âãžã
ãããã·âãã¿ãã³D3æãã¯D2ïŒïŒïŒ24ïŒ25â
ããªããããã·âãã¿ãã³D3æãã¯D2åã³ïŒïŒ
25ïŒ26âããªããããã·âãã¿ãã³D3æãã¯D2
ããèªå°ããããã®ã§ããããããã®äžã§æã奜
ãŸãããã®ã¯ãã¿ãã³D3æãã¯D2ïŒïŒâããã
ãã·âãã¿ãã³D3æãã¯D2åã³ïŒâ25âãžãã
ããã·âãã¿ãã³D3æãã¯D2ã§ããã ãã¿ãã³é¡ã®å€ããããã·ã«å圢æ ç©ã®å Žå
ïŒäŸãã°ãïŒïŒ25âãžããããã·âãã¿ãã³D3ã¯
ïŒïŒïŒåã³25äœã«ïŒåã®ããããã·åºãå«æã
ãïŒãæ¬çºæã®å¥œãŸããååç©ã¯ãè€æ°åã®ãã
ããã·åºã®å šéšæªæºã®ãã®ãã°ãªã³ã·ã«åãããŠ
ãããã®ãæã奜ãŸããã¯è€æ°ã®ããããã·åºã®
ïŒåã®ã¿ãã°ã«ã³ã·ã«åãããŠãããã®ã§ããã ãããã®ã°ãªã³ã·ãé¡ã¯20åãŸã§ã®ã°ã«ã³ã·ã
åäœãå«æããããšãã§ãããããããªããã奜
ãŸãããã®ã¯ã10åæªæºãæã奜ãŸããã®ã¯ïŒå
以äžã®ã°ãªã³ã·ãåäœãæãããã®ã§ãããå ·äœ
äŸãšããŠã¯ãã°ãªã³ã·ãæ®åºäžã«ïŒæãã¯ïŒåã®
ã°ãªã³ã·ãåäœãå«æãããã®ãæããããã ã°ãªã³ãã©ããŒã¹æãã¯ã°ãªã³ãã©ããŒã¹ç°æ
ãã¯ãããã®ã¢ããèªå°äœã¯å®å šã«æãã¯éšåç
ã«ã¢ã·ã«åãããŠããŠããããæãã¯å®å šã«è±ã¢
ã·ã«åãããŠããŠããããå®å šæãã¯éšåçã«ã¢
ã·ã«åãããã°ãªã³ã·ãé¡ã¯ãè±ã¢ã·ã«åç©è³ªã®
åæã®ããã®ç¹å®ã®äžéäœãšããŠæçšã§ããã å¯èœæ§ã®ããã°ãªã³ãã©ãã·ã«æ§é ã®äžã«ã¯ã
ã°ã«ã³ãŒã¹ããã³ããŒã¹ãã¬ã©ã¯ããŒã¹ãã°ããŒ
ã¹ãã¢ããŒã¹ãã¢ã«ãããŒã¹ãã€ããŒã¹ãæãã¯
ã¿ããŒã¹ãªã©ãããããã©ãã·ã«æ§é ã®äžã«ã¯ã
奜ãŸãããã®ãšããŠããã©ã¯ããŒã¹ãã¢ã©ãããŒ
ã¹ãã»ãããªãŒã¹ãã¢ã«ããŒã¹ãã©ã¯ããŒã¹ãã
ã¬ãããŒã¹ãã²ã³ããªããªãŒã¹åã³ã¡ãªããªãŒã¹
ããèªå°ããããã®ãæãããããããªã°ãªã³ã·
ãé¡ã®äžã§å¥œãŸãããã®ã¯ããã©ã¯ããŒã¹ãã¢ã©
ãããŒã¹ãæãã¯ãã·ããŒã¹ããèªå°ããããã®
ã§ããã奜ãŸãããžã°ãªã³ã·ãé¡ã®äžã«ã¯ãã¹ã¯
ããŒã¹ãã»ãããªãŒã¹ããã«ããŒã¹ãã©ã¯ããŒ
ã¹ããã¬ãããŒã¹ãã²ã³ããªããªãŒã¹ãåã³ã¡ãª
ããªãŒã¹ãªã©ããããããªã°ãªã³ã·ãé¡ã®äžã§å¥œ
ãŸãããã®ã¯ã©ãã€ããŒã¹ãæãã¯ã²ã³ãã¢ããŒ
ã¹ã§ãããã¢ããèªå°äœã®äžã«ã¯ãâã¢ã»ãã«
ââã¬ã©ã¯ããµãã³ãâã¢ã»ãã«ââã°ã«
ã³ãµãã³ãâã¢ã»ãã«ââã¢ã³ããµãã³ã
âã¢ã»ãã«ãã€ã©ãã³é žãâã°ã«ã³ãµãã³ããª
ããœã·ã«ã¢ãã³ãâã¬ã©ã¯ããµãã³ãªã©ãã
ãã ïŒåãè¶ããã°ãªã³ã·ãåäœãåäžããããã·
åºäžã«ååšããå Žåã«ã¯ïŒå³ã¡ããžæãã¯ããªã°
ãªã³ã·ãæ®åºïŒãåã ã®ã°ãªã³ã·ãç°ã¯ïŒâïŒïŒ
ïŒâïŒïŒïŒâïŒïŒïŒâïŒïŒïŒâïŒæãã¯ïŒâïŒçµ
åã«ãããæã奜ãŸããã¯ïŒâïŒïŒïŒâïŒåã³ïŒ
âïŒã«ããçµåãããŠããŠããããåã ã®ã°ãªã³
ã·ãç°åå¿ã®çµåã¯Î±æãã¯Î²ã§ããã ãã¿ãã³D3æãã¯D2ååã«ä»çãããããã
ã·åºæãã¯ã°ãªã³ã·ãæ®åºã®é žçŽ çµåã®ç«äœé 眮
ã¯Î±ïŒçŽé¢ã®å€åŽïŒæãã¯Î²ïŒçŽé¢ã®å åŽïŒã®ãã
ãã§ãè¯ããïŒâããããã·æãã¯ïŒ£âïŒã«ãã
ãã°ãªã³ã·ããã·åºã®ç«äœé 眮ãβã§ãããç¬ç«
ã«æãã¯åæã«ïŒ£âïŒã®ããããã·æãã¯ã°ãªã³
ã·ããã·åºã®ç«äœé 眮ãαã§ããããšã奜ãŸã
ããåãâ24ã®å»»ãã®ç«äœé 眮ãã§ããã®ã
奜ãŸãããâ24ã«ãããŠãïŒïŒšã§ãããR2
ïŒCH3æãã¯âCH2CH3ã§ããå Žåã«ã¯ãâ24
ã«ãããç«äœé 眮ã¯å¥œãŸããã¯ïŒ³ã§ããã®ãã
ãã æ¬çºæã®ååç©ã®å ·äœäŸãäžèšã«ç€ºãïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²ââã°ã«ã³ãã©ãã·
ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²ââãã©ã¯ããã©ãã·
ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âã»ãããªã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âãã«ãã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âã©ã¯ãã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâïŒÎ²âãã¬ããã·ãïŒïŒ ãã¿ãã³D3ïŒ3βâã©ãã€ãã·ãïŒ ãã¿ãã³D3ïŒ3βâã²ã³ããªããªã·ãïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²ââ
ã°ã«ã³ãã©ãã·ãïŒïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²ââ
ãã©ã¯ããã©ãã·ãïŒïŒ 1αâããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²âã»ã«
ããªã·ãïŒïŒ 1αâããããã·â3βâïŒÎ²âãã«ãã·ã«ïŒãã¿
ãã³D3ïŒ 1αâããããã·â3βâã©ãã€ãã·ã«âãã¿ã
ã³D3ïŒ 1αâããããã·â3βâã²ã³ããªããªã·ã«âã
ã¿ãã³D3ïŒ 1αâïŒÎ²ââã°ã«ã³ãã©ãã·ã«ïŒâãã¿ãã³
D3ïŒ 1αâïŒÎ²ââãã©ã¯ããã©ãã·ã«ïŒâãã¿ã
ã³D3ïŒ 1αâïŒÎ²âã»ãããªã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âãã«ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âã©ã¯ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâïŒÎ²âãã¬ããã·ã«ïŒâãã¿ãã³D3ïŒ 1αâã©ãã€ãã·ã«âãã¿ãã³D3ïŒ 1αâã²ã³ããªããªã·ã«âãã¿ãã³D3ïŒ 1αïŒ25âãžããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²
ââãã©ã¯ããã©ãã·ãïŒïŒ 1αïŒ25âãžããããã·âãã¿ãã³D3ïŒ3βâïŒÎ²
ââã°ã«ã³ãã©ãã·ãïŒïŒ 1αâïŒÎ²ââã°ãªã³ãã©ãã·ã«ïŒâ25âãã
ããã·âãã¿ãã³D3ïŒ 1αâïŒÎ²ââãã©ã¯ããã©ãã·ã«ïŒâ25âã
ãããã·âãã¿ãã³D3ïŒ 1αâããããã·â25âïŒÎ²ââãã©ã¯ããã©
ãã·ã«ïŒâãã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âã»ãããªã·ã«ïŒâ
ãã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âãã«ãã·ã«ïŒâã
ã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âã©ã¯ãã·ã«ïŒâã
ã¿ãã³D3ïŒ 1αâããããã·ã25âïŒÎ²âãã¬ããã·ã«ïŒâ
ãã¿ãã³D3ïŒ 1αâããããã·ã25âã©ãã€ãã·ã«âãã¿ã
ã³D3ïŒ 1αâããããã·ã25âã²ã³ããªãã·ã«âãã¿
ãã³D3ã äžèšèªå°äœã®å šãŠã¯åããã¿ãã³D2ãçšããŠ
調補ããããšãã§ããã æ¬çºæã®ãã¿ãã³ïŒ€é¡ã®ã°ãªã³ã·ãèªå°äœã¯åœ
æ¥è ã«å ¬ç¥ã®æšæºçåææ¹æ³ã«ãã調補ããããš
ãã§ããããããã®æ¹æ³ã¯åºçºãã¿ãã³D3æã
ã¯D2ãïŒä»¥äžã®ããããã·åºãå«ããåŠãã«ã
ã€ãŠç°ãããã¿ãã³ãå¯äžã®ããããã·åºãæã
ãå Žåã«ã¯ãåæã¯ç°¡åã§ãããå³ã¡ãã¢ããã
ããã·ã«åãã¿ãã³ïŒïŒäœã§ããããã·ã«åïŒã
ãã³ãŒã³æãã¯ãã«ãšã³ãªã©ã®äžæŽ»æ§ãªé極æ§æº¶
åªã®éæµæº¶æ¶²äžã«ãããŠçé žéã§åŠçããããã«
æ«ç«¯ç°ïŒå³ã¡ãæè¬åäžç°ïŒã®ïŒ£â1â²äœã«ãããŠ
é©åœãªé¢è±åºïŒL.G.ïŒãæããå®å šã«ã¢ã·ã«åã
ããã°ãªã³ã·ãæãã¯å®å šã«ã¢ã·ã«åãããçŽé
æãã¯åå²éã°ãªã³ã·ãããªããŒãæ·»å ããã次
ã®åå¿ã«åŸã€ãŠçž®åãèµ·ããããããã§ã¯äŸç€ºã®
ã¿ãç®çãšããŠåäžã°ãªã³ã·ãã«ã€ããŠã®ã¿ç€ºã
ããŠããïŒ ãã®åå¿ç³»åã«ãããŠãR3ã¯åèšã®éãã§ã
ããLGã¯ïŒååæ±æ žçœ®æåå¿ã«ãããŠçœ®æãã
ãããšã®ã§ããèçŽ ãå¡©çŽ ããšãŠçŽ ãïœâãã«ãš
ã³ã¹ã«ããã«ãªã©ã®éåžžã®é¢è±åºã§ããã ãã¿ãã³D3æãã¯D2ãã°ãªã³ã·ãããªããŒãš
åå¿ãããå Žåã«ã¯ãã°ã«ã³ãã©ãã·ãæãã¯ã°
ãªã³ãã©ãã·ãç°äžã®ïŒå以äžã®OCOR3åºã¯ã
ã°ãªã³ã·ãåäœã®ç·æ°ã20ãè¶ããªãããšãæ¡ä»¶
ãšããŠãå®å šã«ã¢ã·ã«åãããã°ãªã³ã·ãåäœã§
眮æãããã åå¿ã¯å®€æž©ä¹è³éæµæ¡ä»¶ã«ãããŠïŒã10æéè¡
ãªãããã®åŸå·åŽåã³éããŠéå¡©ãé€å»ããã
液ã也ç¥ããäžæŽ»æ§æº¶åªãçå»ãããåŸããã
çæç©ãé«æ§èœæ¶²äœã¯ãããã°ã©ãã€ãŒãã±ã€é ž
ã¯ãããã°ã©ãã€ãŒãèå±€äºåã¯ãããã°ã©ãã€
ãŒãªã©ã®æšæºçãªè¿ä»£ç粟補æ¹æ³ã®ä»»æã®ãã®ã«
ãã粟補ããããšãã§ãããéåžžäºã€ã®çæç©ã®
æ··åç©ãåŸããããããã¯ç°çµåç¹ã«ãããαå
ã³Î²ã°ãªã³ãã©ãã·ã«æãã¯ã°ãªã³ãã©ãã·ã«èª
å°äœã§ããããããã¯éåžžäžèšã¯ãããã°ã©ãæ³
ã«ããåé¢ããããšãã§ããã åã ã®çæç©ãåé¢åŸãã°ãªã³ã·ãæ®åºã¯ãã¡
ã¿ããŒã«äžãããªãŠã ã¡ããã·ãæãã¯ã¡ã¿ããŒ
ã«äžã¢ã³ã¢ãã¢ãªã©ã®å¡©åºå ã«ãããŠè±ã¢ã·ã«å
ãããæŽã«é«æ§èœã¯ãããã°ã©ãã€ãŒã«ãã粟補
ãéåžžè¡ããé«åºŠã«ç²Ÿè£œãããçæç©ãåŸãã åºçºãã¿ãã³ïŒ€ïŒD3æãã¯D2ïŒãïŒåã®ããã
ãã·åºïŒäŸãã°ãïŒâããããã·ãã¿ãã³D3ã
æãã¯25âããããã·ãã¿ãã³D3ïŒãæããå Ž
åã«ã¯ããããã®äžã€ã¯ãçž®ååŸäžã€ã°ãªã³ã·ã
æ®åºã®è±ã¢ã·ã«ååãäžãæãã¯åŸã«æçµçã«ã¯
é€å»ããããšã®ã§ããä¿è·åºã§éžæçã«ä¿è·ãã
ãå¿ èŠããããããã¯ïŒå以äžã®ããããã·åºã
ãã¿ãã³åºçºç©è³ªäžã«ååšããå Žåã«ãããŠã¯ãŸ
ãããããã®å ã®å šéšæªæºã®ãã®ãã°ãªã³ã·ã«å
ãããããšãå¿ èŠãšããã åºçºç©è³ªäžã®ããããã·åºã®éžæçä¿è·ã¯ãæ
æ©ååŠã®åœæ¥è ã«åšç¥ã®æšæºçä¿è·åã³è±ä¿è·å
å¿ãçšããŠè¡ãããšãã§ããã ãã¿ãã³ïŒ€ååäžã®åããããã·åºã¯ãããã
äžçŽïŒäŸã26âOHïŒãäºçŽïŒäŸã24âOHã3βâ
OHãªã©ïŒæãã¯äžçŽïŒäŸã25âOHïŒã®ããã
ãã·ã«å®èœåºã®ããããã§ãããšããäºå®ã«ãã
ç°ã€ãåå¿æ§ãæããã®ã§ãéžææ§ãéæããã
ãšãã§ãããæŽã«ãç«äœçèæ ®ã«ããã3βâOH
ã¯ãé£æ¥ããããã·ã«å®èœåºã§ãããšå ±ã«C10äž
ã®ç°å€C19ã¡ãã¬ã³å®èœåºã«ãã€ãŠç«äœçã«åŠšã
ãããŠãã1αâOHãšã¯ç°ã€ãåå¿æ§ãæããã
ãããã®åå¿æ§ã®å¥œäŸã¯ããªãã¯ïŒHolickïŒç
ã«ãããBiochemistryïŒ10å·»ã2799ïŒ1971幎ã«
äŸç€ºãããŠããããã®æç®ã«ã¯ãïŒïŒ25âïŒOHïŒ
2âD3ã®ããªã¡ãã«ã·ãªã«ãšãŒãã«èªå°äœãHC1
âMeOHäžã«ãããŠæž©åãªæ¡ä»¶äžã«ããããã·
ã«åããŠïŒïŒ25âïŒOHïŒ2âD3ã®ïŒïŒ25âãžã·ãª
ã«ãšãŒãã«åã³25âã¢ãã·ãªã«ãšãŒãã«èªå°äœã
åŸãããšãã§ããããšã瀺ãããŠãããæŽã«ãïŒ
åã³ïŒã®ããããã·ã«ãä¿è·ãããŠããïŒïŒ25â
ïŒOHïŒ2âD3ãåŸãããã«ã¯ãïŒïŒ25âïŒOHïŒ2â
D3ã®25âã¢ãã·ãªã«ãšãŒãã«èªå°äœãã¢ã»ãã«
åããŠïŒïŒ25âïŒOHïŒ2âD3âïŒïŒïŒâãžã¢ã»ã
ã«â25âããªã¡ãã«ã·ãªã«ãšããŒã«ã圢æããã
ãšãã§ãããã¢ã»ããŒãé¡ã¯é žå æ°Žå解ã«å¯ŸããŠ
極ããŠå®å®ã§ããã®ã§ããã®èªå°äœãé žå æ°Žå解
ããŠïŒïŒïŒâãžã¢ã»ããã·â25âããããã·ãã¿
ãã³D3ãåŸãããšãã§ããã代æ¿çææ³ã¯åã«
ïŒïŒ25âïŒOHïŒ2âD3ãããªãžã³äžã®ç¡æ°Žé ¢é žäž
ã«ãããŠå®€æž©ã§24ã48æéã¢ã»ãã«åããŠïŒïŒïŒ
âãžã¢ã»ããã·â25âããããã·ãã¿ãã³D3ã
åŸãããšã§ãããã 25âããããã·ãã¿ãã³D3ã«å¯ŸããŠ25âãã
ããã·ã«åºãä¿è·ããããã«ã¯ã次ã®ããšãè¡ã
ããšãã§ããïŒå³ã¡ã25âOHâD3ã¯ç¡æ°Žé ¢é žå
ã³ããªãžã³äžã«ãããŠéæµæ¡ä»¶äžã«24æéã§å®å š
ã«ã¢ã»ãã«åããããšãã§ãããïŒâAcã¯å®€æž©
ã«ãããŠ12æéã±ã³åïŒ95ïŒ MeOHâæ°Žäžã®
KOHïŒã«ããéžæçã«é€å»ããããšãã§ããã äžåºŠææã®ä¿è·ãã¿ãã³ïŒ€èªå°äœã調補ããã
ãšããããçé žéãšåå¿ããããäžèšåå¿åŒã®
åŠãã°ãªã³ã·ãæãã¯ããªã°ãªã³ã·ãæ®åºãšåå¿
ããã次ãã§è±ã¢ã·ã«åãè±ä¿è·åºåã³ç²Ÿè£œãè¡
ããçé žé以å€ã®ãã®ãçšããæ¹æ³ãæ¡çšã§ãã
äŸãã°ãK.IgaraâshiãâAdvances in
Carbohydrate Chemistry and Biochemistryâ
34å·»ã243â283ãæãã¯C.D.WarrençCarbohâ
ydrate Researchã82å·»ïŒ71â83ïŒ1980幎ïŒã®èš
èŒãæããããšãã§ããã 容æã«å©çšå¯èœãªåºçºãã¿ãã³ïŒ€èªå°äœãšããŠ
ã¯ãäžèšã®ãã®ãæããããïŒ ãã¿ãã³D3ïŒ ãã¿ãã³D2ïŒ ïŒâããããã·âãã¿ãã³D3ïŒ ïŒâããããã·âãã¿ãã³D2ïŒ 25âOHâãã¿ãã³D3ïŒ 25âOHâãã¿ãã³D2ïŒ ïŒïŒ24âïŒOHïŒ2âãã¿ãã³D3ïŒ ïŒïŒ25âãžããããã·âãã¿ãã³D3ïŒ ïŒïŒ25âãžããããã·âãã¿ãã³D2ïŒ 24ïŒ25âãžããããã·âãã¿ãã³D3ïŒ 25ïŒ26âãžããããã·âãã¿ãã³D3ïŒ 24ïŒ25âãžããããã·âãã¿ãã³D2ïŒ ïŒïŒ24ïŒ25âããªããããã·âãã¿ãã³D3ïŒ ïŒïŒ25ïŒ26âããªããããã·âãã¿ãã³D3ã ããçš®ã®ç©è³ªãäŸãã°ã25ïŒ26âãã¿ãã³D2ïŒ
ïŒïŒ24ïŒ25âããªããããã·ãã¿ãã³D2æãã¯
ïŒïŒ25ïŒ26âããªããããã·ãã¿ãã³D2ã¯åœå
éã«ãããŠæªã ååã«åå®ãããŠããªããããã
ããåæçã«èª¿è£œããããªãã°äœ¿çšããããšãå¯
èœã§ããã 第äžïŒæãã¯å¯äžïŒã®ã°ãªã³ã·ãç°ã®ïŒ£â1â²äœ
ã«é¢è±åºãæããã¢ã·ã«åã°ãªã³ã·ãã¯ãäŸã
ã°ããã¬ããã€ãŒïŒH.G.Fletcher Jr.ïŒã®
âMethodsin Carbohydrate ChemistryâïŒå·»ïŒ
228ïŒ1963幎ïŒæãã¯ãããŒïŒW.A.BonnerïŒã®
âJournal of Organic Chemistryâ26å·»ïŒ908â
911ïŒ1961幎ïŒãæãã¯ã«ããŠãŒïŒR.U.LemieuxïŒ
ã®âMethods in Carbâohydrate Chemistryâã
第巻ã221ïŒ222ã«èšèŒãããŠããæ¹æ³ã«ãã調
補ããããšãã§ããã ãªãªãŽãµãã«ã©ã€ãäžéäœã¯ãäŸãã°ãã«ããŠ
ãŒãR.U.LemieuxãJ.of Amer.Chem.Soc.97
å·»ïŒ4063â4069ïŒ1975幎ïŒãããã¬ã·ãšãããJ.M.
J.FrechetïŒâPolymerâSuppoârted Reactions
in Organic SynthâesisâïŒ1980幎ïŒ407â434ãã
æãã¯ã±ããã€ãJ.F.KennedyãâCarbohydrate
CheâmistryâïŒå·»ïŒ496â585ïŒ1975幎ïŒãã®æ¹æ³
ã«ãã調補ããããšãã§ããã åžè²©ã®ç³é¡ãšããŠã¯æ¬¡ã®ãã®ãæãããã
ïŒPfaânstiehl LaboratoriesïŒIncïŒïŒïŒãã³ããŒ
ã¹é¡ãäŸãã°ãâã¢ã©ãããŒã¹ãâã¢ã©ãã
ãŒã¹ãâãªããœãŒã¹ãâãªããœãŒã¹ãâãª
ããŒã¹ãâãã·ããŒã¹ãâãã·ããŒã¹ãªã©ã
ãããœãŒã¹é¡ãäŸãã°ãããã¹ãããŒã¹ãâã
ã©ã¯ããŒã¹ãâã¬ã©ã¯ããŒã¹ãαââã°ã«ã³
ãŒã¹ãβââã°ã«ã³ãŒã¹ãâã°ã«ã³ãŒã¹ãã¬
ãããŒã¹ãâãã³ããŒã¹ãâãã³ããŒã¹ã
âãœã«ããŒã¹ãªã©ãããããŒã¹é¡ãäŸãã°ãâ
ã°ã«ã³ããããŒã¹ãâãã³ããããããŒã¹ãã»
ãããããã¶ã³ãªã©ããžãµãã«ã©ã€ãé¡ãäŸã
ã°ãã»ãããªãŒã¹ãïŒââβââã¬ã©ã¯ãã
ã©ãã·ã«ââã¢ã©ãããŒã¹ãã²ã³ããªããªãŒ
ã¹ãã©ã¯ããŒã¹é¡ãαâã©ã¯ãããŒã¹ããã«ããŒ
ã¹ãαâã¡ãªããªãŒã¹ãã¹ã¯ããŒã¹ããã¬ãããŒ
ã¹ããã©ããŒã¹ãªã©ãããªãµãã«ã©ã€ãé¡ãäŸã
ã°ãã¡ã¬ãããŒã¹ãã©ãã€ããŒã¹ãªã©ãããã©ãµ
ãã«ã©ã€ãé¡ãäŸãã°ãã¹ã¿ããªãŒã¹ãªã©ãããª
ãµãã«ã©ã€ãé¡åã³ãã®èªå°äœãäŸãã°ãã¢ã©ã
ã³é žãããã€ã³ãããã¶ã³ãããã¹ããªã³ãã·ã¯
ãâããã¹ããªã³é¡ãã°ãªã³ãŒã²ã³ãã€ããªã³ãª
ã©ã æãã¯åãå šåæçµè·¯ïŒä¿è·ãçž®ååã³è±ä¿
è·ïŒããããã¿ãã³ïŒ€ã§ããÎ5,7ã¹ããã€ããžãš
ã³ãåºçºç©è³ªãšããŠçšããŠè¡ãããšãã§ãããã°
ãªã³ã·ã«ååŸããã®ãããã¿ãã³ãå ååŠçã«é
ç°ããåŸããããããã¿ãã³ãç±çã«åé åããŠ
ã°ãªã³ã·ã«åãã¿ãã³ãåŸãã ãã¿ãã³ïŒ€ã®æŽ»æ§åœ¢æ ç©ã¯ãïŒïŒ25âãžããã
ãã·ãã¿ãã³D3ã§ããããšãç¥ãããŠããããJ.
L.Napoliåã³H.F.DeLucaïŒâBurger's
Medicinal Chemistryâ第ïŒçã第éšã728ff
é ããïŒïŒ25âãžããããã·âãã¿ãã³D3ã°ãªã³
ã·ããäœã«ã«ã·ãŠã è¡çç¶æ ã®æ²»çã«æãã¯å
ç©ãç¹ã«ããã«ããããªã³åã³ã«ã«ã·ãŠã 代è¬ã®
å¶åŸ¡ã«äœ¿çšãããå Žåã«ã¯ãåç©ã®å å æ§ã°ãªã³
ã·ããŒãŒé µçŽ ãçŽæ¥çã«ãã®ãã¿ãã³ã®æŽ»æ§åœ¢æ
ç©ãæŸåºãããä»æ¹ããã®ãã¿ãã³ã®éãããã
ã·ã«åèªå°äœã䜿çšãããå Žåã«ã¯ïŒäŸãã°ãã
ã¿ãã³D3ã°ãªã³ã·ãïŒãããããã·ã«åãã¿ãã³
ã®é µçŽ ã«ããæŸåºã«ç¶ããŠã掻æ§ïŒïŒ25âãžãã
ããã·ãã¿ãã³ã圢æããããã«ãèèã次ãã§
è èã«ãããŠããããã·ã«åãè¡ãããã æ¬çºæã®æ°Žæº¶æ§ã°ãªã³ã·ã«åãã¿ãã³ïŒ€è€åäœ
ã¯ã芪氎æ§ã®è¯å¥œãªæ°Žæº¶æ§èªå°äœä¹è³åªãã氎溶
æ§ã®èªå°äœãå å«ããããããã¯ãäžè¬çã«ãåŸ
æ¥ãã¿ãã³D3ããã¿ãã³D2æãã¯ãããã®ãã
ããã·ã«åèªå°äœãå¿ èŠãšãããŠããä»»æã®çšé
ã«äœ¿çšããããšãã§ãããæ¬çºæã®è€åäœã®å©ç¹
ã¯ããããã®æ°Žæº¶æ§ã«ãããåŸã€ãŠãäŸãã°ãå¡©
æ°Žæãã¯æ°Žæ§ç·©è¡æ¶²ã®ãããªæ°Žæ§åªäœã«ãããæ
äžã®å®¹ææ§ã«ãããããã¯ããããã®è€åäœãã
ã¿ãã³ïŒ€æŸåºã€ã³ã©ã€ã³ãã³ããéèå åé åšãª
ã©ã®è£ 眮ã«ãããŠå©çšããããšãå¯èœã«ãããã
ã®ä»ã®å©ç¹ãšããŠã¯ãèèªæªåžåçå矀ã®æ²»ç䞊
ã³ã«è žã«ãããçç©åŠçã«æŽ»æ§åœ¢æ ã®ãã¿ãã³
D3ã®æŸåºãäŸãã°ãïŒïŒ25âïŒOHïŒ2âD3ã°ãªã³
ã·ãâè žâïŒïŒ25âïŒOHïŒ2âD3âçç©åŠçäœçš
ãªã©ãæããããã æ¬çºæã®è€åäœã¯ãåç©ãç¹ã«ããã«ãããã«
ã«ã·ãŠã åã³ãªã³ã®ãã¡ãªã¹ã¿ã·ã¹åã³ä»£è¬ã®å¶
埡ãè¡ãä»»æã®æ段ã«ããæäžããããšãå¯èœã§
ãããäŸãã°ãæäžã¯å±æçãéçµå£çãç®äžã
ç®å ãéèå ãçèå æãã¯è ¹è å ã«è¡ãããšã
ã§ãããããããšã¯å¥ã«ãæãã¯åæã«ãæäžã¯
çµå£çã«è¡ãããšãã§ãããæäžéã¯ãå容è ã®
幎什ãå¥åº·åã³äœéãåæã«è¡ãããæ²»çã®çš®
é¡ãæ²»çã®é »åºŠåã³ææãšãããå¹æã®æ§è³ªã«å¿
ããŠç°ããäžè¬çã«ã¯ã掻æ§æåååç©ã®æäžé
ã¯äœéKgåœãçŽ0.1ÎŒïœãïŒmgã§ãããéåžžãææ
ã®çµæãåŸãããã«ã¯ãæ²»çã®ããã®ïŒå以äžã®
æœçšã«ãããŠãæœçšåœã0.1ÎŒïœã10ÎŒïœïŒKgãæ
å¹ã§ããã æ¬çºæã®ååç©ã®æŽã«äºæ³å€ã®æ§è³ªã¯ãããã
ã®ãããã®ãã骚ããã®ã«ã«ã·ãŠã æŸåºã«ããã
ãããããã«ã«ã·ãŠã åå¡ãèµ·ããããšãªãè žã
éããŠã®ã«ã«ã·ãŠã åžåã®ä¿é²ã瀺ãããšã§ã
ãã骚æŸåºã«ããã«ã«ã·ãŠã åå¡ã¯ãïŒïŒ25âãž
ããããã·ãã¿ãã³D3ã®å ±éã®ç¹åŸŽã§ãããæ¬
çºæã®ååç©ã®ãããã®ã«ãããããã®éžæçäž
ååšã¯ãè žã®ã«ã«ã·ãŠã 茞éãåºæããããšã«ã
ã€ãŠè¡æž ã«ã«ã·ãŠã æ¿åºŠã®å¢å€§ãä¿é²ããããšã«
ãã奜ãŸããæ²»ççµæããããããéã骚ã®ç ã
æããæ£è ã«ãšã€ãŠã圌çã®æ¢ã«æ¶èãã骚ãã
ã®ã«ã«ã·ãŠã ãåå¡ãããšããç ç²ã«ãã€ãŠè¡æž
ã«ã«ã·ãŠã æ¿åºŠãç¶æããããšã¯äžå©ãªããšã§ã
ãã æ¬çºæã®ååç©ã¯ãçµå£æäžçšã«ãé å€ãã«ã
ã»ã«ãç²æ«å æãã¯æ¶²äœæº¶æ¶²ãæžæ¿æ¶²æãã¯ãšãª
ãã·ã«ãªã©ãæãã¯éçµå£çšéã®ããã«ã溶液æ
ãã¯æžæ¿æ¶²ãªã©ã®ç¡è調å€æ¶²ã®æäžåœ¢æ ã§äœ¿çšã
ãããšãã§ããããã®æ§ãªçµæç©ã«ãããŠã掻æ§
æåã¯ãéåžžãçµæç©ã®å šééã®å°ãªããšãïŒÃ
10-6ééïŒ ãããã90ééïŒ ä»¥äžã®éã§åžžã«ååš
ãããäžæŽ»æ§ãªè¬åŠçã«èš±å®¹å¯èœãªæ äœã䜿çšã
ãã®ã奜ãŸããããã®æ§ãªæ äœãšããŠã¯ã95ïŒ ãš
ã¿ããŒã«ãæ€ç©æ²¹ããããã¬ã³ã°ãªã³ãŒã«é¡ãå¡©
æ°Žç·©è¡æ¶²ãªã©ãå«ãŸããã 以äžãäžè¬çã«æ¬çºæã説æããããç¹å®ã®å ·
äœäŸãåç §ããããšã«ããæŽã«å®å šã«ç解ããã
ãšãã§ããããããã®äŸã¯äŸç€ºã®ã¿ãç®çãšããŠ
瀺ããããã®ã§ãããç¹ã«æãã®ãªãéããæ¬çº
æãéå®ãã趣æšã®ãã®ã§ã¯ãªãã äŸ ïŒ ãã¿ãã³D3ïŒ3βâã°ãªã³ã·ãã®èª¿è£œ èœäžæŒæåã³èžçé éšãä»å±ãã100mlã®äžã€
éŠäžžåºãã©ã¹ã³å ã«ãããŠã147mgïŒ0.382ããªã¢
ã«ïŒã®ãã¿ãã³D3ã溶解ããã5mlã®ä¹Ÿç¥ãã³ãŒ
ã³äžã«ããã«ãŒïŒBeckerïŒãBiochem.Biophys.
ActïŒ100ïŒ574â581ïŒ1965ïŒãã®æ¹æ³ã«åŸã€ãŠæ°
ããã«èª¿è£œããã1.00ïœïŒ3.63ããªã¢ã«ïŒã®ä¹Ÿç¥
çé žéãæžæ¿ãããããã®æº¶æ¶²ã沞ãšããããã
ãã®æç¹ã«ãããŠã25mlã®ãã³ãŒã³ã«æº¶è§£ãã
äžèšã¬ããŠãŒïŒLemieuxïŒã®æ¹æ³ã«åŸã€ãŠèª¿è£œ
ããã647mgïŒ1.57ããªã¢ã«ïŒã®ããã©ââã¢
ã»ãã«âβââã°ã«ã³ãã©ãã·ã«ãããã€ãã
滎äžããããã³ãŒã³ã®èžçãç¶ç¶ããçŽ1/2æé
åŸã«æŽã«çé žéïŒçŽ1gïŒãåå¿æ¶²ã«æ·»å ããã
åå¿åŸãèå±€ã¯ãããã°ã©ãã€ãŒïŒ20ïŒ80vïŒïœ
é ¢é žãšãã«ïŒãããµã³ïŒãè¡ã€ããåŸããçæç©
ã¯0.24ã®Rfãæããäž»ããçæç©ã¯0.20ã®Rfãæ
ãããïŒæéåŸã«åå¿æ¶²ãå·åŽããã¬ã©ã¹ãŠãŒã«
ãéããŠéããŠéå¡©ãé€å»ããã液ãç¡æ°Žç¡«
é žãããªãŠã äžã§ä¹Ÿç¥ãããã³ãŒã³ãçªçŽ äžã«ç
å»ãããåŸããé»è²æ²¹ãäºåÎŒâPorasilé«å§æ¶²
äœã¯ãããã°ã©ãã«ã©ã ïŒå¯žæ³ïŒmmÃ30cmãæµé
2mlïŒåã溶åª15/85ïœïŒïœé ¢é žãšãã«ïŒãããµ
ã³ïŒã«ããããäž»ããçæç©ãïŒïŒ10âã»ã³ã³ã¬
ã¹ã¿âïŒïŒïŒïŒ10ïŒ19ïŒâããªãšã³â3βâã€ã«â
2â²ïŒ3â²ïŒ4â²ïŒ6â²âããã©ââã¢ã»ãã«âβâ
âã°ã«ã³ãã©ãã·ãã®ä¿ææéã¯58åã§ãããã
ã¿ãã³ïŒ€äžã®ããªãšã³çºè²å£ã«ç¹æ§çãª265nmã®
æ倧åžå 床åã³228nmã®æå°åžå 床ã瀺ãããã
ã®è³ªéã¹ãã¯ãã«ã¯èŠªååã€ãªã³ã®ããŒã¯ãïœïŒ
e714ïŒ2.5ïŒ ïŒM+ïŒã«å«ã¿ãããŒã¯ã383ïŒïŒïŒ
ïŒïŒâããããŠã ã€ãªã³ïŒïŒ366ïŒ28ïŒ ïŒïŒâãã
ããŠã ã€ãªã³âæ°ŽïŒ+ïŒ351ïŒ18ïŒ ïŒ331ïŒ15ïŒ ïŒã
ãããŠã ã€ãªã³ïŒ+ïŒ271ïŒ2.5ïŒ ïŒ253ïŒ14ïŒ ïŒ
169ïŒ100ïŒ ïŒïŒC8H9O4ïŒ+ïŒ109ïŒ63ïŒ ïŒC6H5O2ïŒ
ïŒïŒåã³60ïŒ20ïŒ ïŒã®é žã¡ãã«æãã¯é ¢é žïŒã«äœ
ã€ããåŸããçæç©ãïŒïŒ10âã»ã³ã³ã¬ã¹ã¿â
ïŒïŒïŒïŒ10ïŒ19ïŒâããªãšã³â3βâã€ã«â2â²ïŒ3â²ïŒ
4â²ïŒ6â²âããã©ââã¢ã»ãã«âαââã°ã«ã³
ãã©ãã·ãã®ä¿ææéã¯45åã§ãããå265nmã«
ãããæ倧åžå 床åã³228nmã«ãããæå°åžå 床
ã瀺ããããã®è³ªéã¹ãã¯ãã«ã¯ïœïŒe714ã®åå
ã€ãªã³ã瀺ããã 58åã®ä¿ææéãæããäž»ããçæç©ã次ãã§
ãããªãŠã ã¡ããã·ãåã³ã¡ã¿ããŒã«ãçšããŠè±
ã¢ã·ã«åãããç¡æ°Žã¡ã¿ããŒã«äžã«æº¶è§£ããåå
ç©ã«ãããªãŠã éå±ã®å°çãæ·»å ããã1/2æé
åŸæº¶æ¶²ãçšé ¢é žã§äžåããããã®æº¶æ¶²ãçªçŽ äžã«
也ç¥ãã次ãã§éçžé«å§æ¶²äœã¯ãããã°ã©ãã«ã©
ã ïŒRadial PakA column Waters AssociatesïŒ
寞æ³0.8Ã10cmãæµé1mlïŒåã溶åª98/2ïœïŒïœã¡
ã¿ããŒã«ïŒæ°ŽïŒã«ããããçæç©ãïŒïŒ10âã»ã³
ã³ã¬ã¹ã¿âïŒïŒïŒïŒ10ïŒ19ïŒããªãšã³â3βâã€ã«
âβââã°ã«ã³ãã©ãã·ãã®ä¿ææéã¯12.5å
ã§ããããã¿ãã³ïŒ€çºè²å£ã«å žåçãªÎ»nax
265nmãλnio228nmã®UVã¹ãã¯ãã«ã瀺ããã ãã¿ãã³D3ïŒ3βâã°ã«ã³ã·ãããã¿ãã³D3ïŒ
3αâã°ã«ã³ã·ãåã³ãã¿ãã³D3ïŒ3βã°ã«ã³ã·ã
ã¢ã»ããŒãã®çç©åŠç掻æ§ã®è©Šéšãè¡ã€ãã
Holtzmann瀟ïŒç±³åœããŠã€ã¹ã³ã³ã·ã³å·ã
MadisonïŒããåŸãããéã®ä¹³é¢ãããã°ããã®
ã©ããã«ãªã³ã¯é©æ§ã§ãããã«ã«ã·ãŠã ã®äœã
ïŒ0.02ïŒ ïŒãã¿ãã³ïŒ€æ¬ ä¹ã®é£é£ŒãïŒâ1/2é±éäž
ãããïŒå¹ã®åç©çŸ€ã«çµå£çã«4ÎŒïœã1ÎŒïœã0.5ÎŒ
ïœã0.25ÎŒïœãã¿ãã³D3â3βâã°ã«ã³ã·ãã1ÎŒïœ
ã®ãã¿ãã³D3â3αâã°ã«ã³ã·ãæãã¯2ÎŒïœã®ã
ã¿ãã³D3â3βâã°ã«ã³ã·ãã¢ã»ããŒãã50ÎŒlã®
95ïŒ ãšã¿ããŒã«ã«æº¶è§£ãããã®æãã¯çšéå€åç¬
ãæäžããã24æéåŸã«åç©ã殺ããå°è žåã³è¡
液ãéãããè žã«ã«ã·ãŠã 茞éç 究ãè£è¿ãè žè¢
æè¡ã«ããè¡ããè¡æ¶²ã¯è¡æž ã«ã«ã·ãŠã 枬å®ã«äœ¿
çšãããçµæãäžè¡šã«ç€ºãã
ãè¡šã
ã¢ã»ããŒã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1982/000882 WO1984000107A1 (en) | 1982-06-30 | 1982-06-30 | Vitamin d glycosides |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59501264A JPS59501264A (ja) | 1984-07-19 |
JPH0428717B2 true JPH0428717B2 (ja) | 1992-05-15 |
Family
ID=22168069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57502412A Granted JPS59501264A (ja) | 1982-06-30 | 1982-06-30 | ãã¿ãã³ïœã°ãªã³ã·ãé¡ |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0112332B1 (ja) |
JP (1) | JPS59501264A (ja) |
AT (1) | ATE90564T1 (ja) |
WO (1) | WO1984000107A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3565401D1 (de) * | 1984-02-08 | 1988-11-10 | Hoffmann La Roche | Calciferol derivatives |
US5110958A (en) * | 1984-02-08 | 1992-05-05 | Hoffmann-La Roche Inc. | Compounds, process and intermediates |
ATE123306T1 (de) * | 1989-05-19 | 1995-06-15 | Hayashibara Biochem Lab | Alpha-glycosyl-l-ascorbinsÀure und ihre herstellung und verwendungen. |
JPH05286992A (ja) * | 1992-04-13 | 1993-11-02 | Mect Corp | æ°èŠã·ã¢ãªã«ã¹ããã€ã |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5732051B2 (ja) * | 1974-01-24 | 1982-07-08 | ||
US4188345A (en) * | 1978-07-26 | 1980-02-12 | Wisconsin Alumni Research Foundation | Fluorovitamin D compounds and processes for their preparation |
US4292250A (en) * | 1980-11-17 | 1981-09-29 | Wisconsin Alumni Research Foundation | Vitamin D derivatives |
-
1982
- 1982-06-30 EP EP82902413A patent/EP0112332B1/en not_active Expired - Lifetime
- 1982-06-30 WO PCT/US1982/000882 patent/WO1984000107A1/en active IP Right Grant
- 1982-06-30 JP JP57502412A patent/JPS59501264A/ja active Granted
- 1982-06-30 AT AT82902413T patent/ATE90564T1/de not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
J.BIOLOGICAL CHEMISTRY=1977 * |
LIFE SCIENCE=1976 * |
Also Published As
Publication number | Publication date |
---|---|
EP0112332A1 (en) | 1984-07-04 |
JPS59501264A (ja) | 1984-07-19 |
EP0112332A4 (en) | 1985-08-12 |
EP0112332B1 (en) | 1993-06-16 |
ATE90564T1 (de) | 1993-07-15 |
WO1984000107A1 (en) | 1984-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4410515A (en) | Vitamin D glycosides and a method of use | |
US4661294A (en) | Biologically active 1-thio derivatives of vitamin D | |
US4521410A (en) | Vitamin D glycosyl orthoesters | |
US7122530B2 (en) | 24-hydroxyvitamin D, analogs and uses thereof | |
US4457918A (en) | Glycosides of vitamins A, E and K | |
US4358406A (en) | 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same | |
Yu et al. | Carbohydrate chemistry in the total synthesis of saponins | |
US4226788A (en) | 24,24-Difluoro-1α,25-dihydroxycholecalciferol | |
EP2515913A2 (en) | Use of vitamin d glycosides and sulfates for treatment of disease | |
Chen et al. | Convergent synthesis and cytotoxic activities of 26-thio-and selenodioscin | |
EP0676951B1 (en) | Use of vitamin d glycosides for the treatment or prevention of osteoporosis | |
US4201881A (en) | 24,24-Difluoro-1α,25-dihydroxycholecalciferol | |
WO1982002893A1 (en) | 1 alpha,25-dihydroxy-2 beta-fluorovitamin d3 | |
EP0112332B1 (en) | Vitamin d glycosides | |
Ikeda et al. | Synthesis of neosaponins having an α-l-rhamnopyranosyl-(1â 4)-[α-l-rhamnopyranosyl-(1â 2)]-d-glucopyranosyl glyco-linkage | |
Lahmann et al. | A facile approach to diosgenin and furostan type saponins bearing a 3β-chacotriose moiety | |
GB2074577A (en) | 1-hydroxy-2-fluorocholecalciferol | |
GB2044770A (en) | 24,24 - difluoro- 25 - hydroxycholecalciferol | |
CA1219581A (en) | Vitamin d glycosides and a method for use | |
US5693767A (en) | Glycoside derivatives of acetaminophen | |
JP2888773B2 (ja) | æççäœçšãæããç³è質 | |
JPH1160593A (ja) | æççäœçšãæããç³è質 |